小白土兔的个人主页 - 老虎社区

小白土兔

小白土兔

暂无个人介绍

IP属地：江苏

25关注

3粉丝

2主题

0勋章

04-24

什么鬼都能上市圈钱了

“新茶饮第二股”茶百道登陆港交所主板多家茶饮品牌加速推进上市

03-19

亿航开盘即巅峰，现在竟然能变成跌的，真的拉胯啊

盘前 | 谷歌涨超5%！超微电脑、英伟达涨逾3%；“空中的士”淘宝开售，亿航智能涨超13%

03-13

都熄火了

03-13

又开始炒作中概股，缺韭菜了吧

03-13

和朋友聊到我在美股的中概股亏了很多钱，他说，人家中国企业不远万里是想着去割外国资本主义的韭菜，你倒好，非要跑去让人家割，被大a割的还不够吗？你亏了活该。从此再也不碰中概股。中概股玩法和a股一样，没有武德，没有价值投资，中国人就别去被骗了吧

03-12

中概股和大a一样，先腰斩再腰斩，然后疯涨20%哈哈哈哈。然后就说狂欢了。

2023-12-26

$Iovance Biotherapeutics, Inc.(IOVA)$ 你啥时候也被收购啊

2023-10-31

生存率好低啊

Iovance Biotherapeutics to Present Clinical and Pre-Clinical Data for Tumor Infiltrating Lymphocyte (TIL) Therapies at Society for Tumor Immunotherapy of Cancer’s (SITC) 38th Annual Meeting

2023-03-16

垃圾

抱歉，原内容已删除

2023-03-16

$箩筐技术(LKCO)$ 这个**公司去哪里骂他们

2023-03-13

$箩筐技术(LKCO)$ 都是谁在买这垃圾股，哎

2023-02-22

$箩筐技术(LKCO)$ 箩筐之前合股过吗

2023-02-22

$箩筐技术(LKCO)$ 要合股了？

2023-02-14

$世纪互联(VNET)$ 扶不起的阿斗，新任的董真是垃圾

2023-01-12

$箩筐技术(LKCO)$ 是不是要退市了

2021-10-22

$Beyond Meat, Inc.(BYND)$真是不争气

2021-02-26

涨在哪里？

Beyond Meat涨10%，宣布与百胜餐饮、麦当劳建立合作关系

2021-02-26

哈？

抱歉，原内容已删除

2020-12-04

$箩筐技术(LKCO)$好想卖你…

2020-11-25

$箩筐技术(LKCO)$有意思吗？一天回去

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":3537417120281286,"uuid":"3537417120281286","gmtCreate":1574323097824,"gmtModify":1579744356528,"name":"小白土兔","pinyin":"xbttxiaobaitutu","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/ed03e24159cdfb1a1cc9e0eb75d70106","hat":"https://static.tigerbbs.com/0a8758340a08196056f8bc1e54805193","hatId":"ca_profile_frame_Lm11L6","hatName":"","vip":1,"status":2,"fanSize":3,"headSize":25,"tweetSize":36,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":2,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":1,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.04.17","exceedPercentage":"93.62%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-3","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"偶像虎友","description":"加入老虎社区1500天","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.12.31","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"228c86a078844d74991fff2b7ab2428d-2","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资总监虎","description":"证券账户累计交易金额达到30万美元","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"80.02%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":5,"crmLevelSwitch":0,"location":"江苏","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":298692875362304,"gmtCreate":1713931923490,"gmtModify":1713931925456,"author":{"id":"3537417120281286","authorId":"3537417120281286","name":"小白土兔","avatar":"https://static.tigerbbs.com/ed03e24159cdfb1a1cc9e0eb75d70106","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"什么鬼都能上市圈钱了","listText":"什么鬼都能上市圈钱了","text":"什么鬼都能上市圈钱了","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/298692875362304","repostId":"2429213117","repostType":2,"repost":{"id":"2429213117","pubTimestamp":1713889847,"share":"https://www.laohu8.com/m/news/2429213117?lang=&edition=full","pubTime":"2024-04-24 00:30","market":"hk","language":"zh","title":"“新茶饮第二股”茶百道登陆港交所主板 多家茶饮品牌加速推进上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2429213117","media":"证券日报","summary":"4月23日，新茶饮品牌“茶百道”母公司四川百茶百道实业股份有限公司（以下简称“茶百道”）正式于港交所主板挂牌。本次茶百道发行1.48亿股H股，发行价为每股17.50港元，募资总额高达25.9亿港元。招股书显示，本次募集资金主要用于提高整体运营能力及强化供应链、发展数字化能力以及委聘和培训专业人才等。","content":"<html><body><div>\n<p><img border=\"0\" height=\"276\" src=\"https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=116.02555&amp;imageType=k&amp;token=28dfeb41d35cc81d84b4664d7c23c49f&amp;at=1\" width=\"578\"/></p><p>　　4月23日，新茶饮品牌“<span><a href=\"https://laohu8.com/S/02555\">茶百道</a></span>”母公司四川百<span href=\"http://quote.eastmoney.com/unify/r/116.02555\" target=\"_blank\" web=\"1\">茶百道</span>实业股份有限公司（以下简称“<span href=\"http://quote.eastmoney.com/unify/r/116.02555\" target=\"_blank\" web=\"1\">茶百道</span>”）正式于港交所主板挂牌。本次茶百道发行1.48亿股H股，发行价为每股17.50港元，募资总额高达25.9亿港元。</p> <p>　　招股书显示，本次募集资金主要用于提高整体运营能力及强化供应链、发展数字化能力以及委聘和培训专业人才等。</p> <p>　　中国企业资本联盟副理事长柏文喜对《<span>证券</span><span></span>日报》记者表示：“茶百道的上市不仅凸显了新茶饮市场的发展空间，还体现了资本市场对新茶饮行业的青睐。”</p> <p>　　<strong>加速布局下沉市场</strong></p> <p>　　茶百道招股书显示，公司成立于2008年，首家门店开在成都。2021年至2023年，茶百道收入分别为36.44亿元、42.32亿元、57.04亿元，毛利分别为13.01亿元、14.56亿元、19.64亿元，同期毛利率分别为35.7%、34.4%及34.4%。</p> <p>　　截至2024年4月5日，茶百道门店数已经达到8016家，实现所有省份及各线级城市的全覆盖。根据弗若斯特沙利文的报告，2023年，中国现制茶饮店市场规模为2473亿元。按零售额计，前五大参与者合共占据约40.2%的市场份额，茶百道以约6.8%的市场份额位居第三。</p> <p>　　茶百道门店主要分布在新一线城市和二线城市，同时，三四线城市门店数量的占比也在提高。</p> <p>　　招股书显示，到2023年底，茶百道门店在一线、新一线、二线、三线、四线及以下城市的数量占比分别为10.6%、26.9%、20.9%、19.4%及22.2%。茶百道称，低线级城市存在较大的市场空间，因此计划进一步在二线及以下的城市进行门店加密，抢占下沉市场。</p> <p>　　<span><a href=\"https://laohu8.com/S/00506\">中国食品</a></span>产业研究院高级研究员朱丹蓬对《<span href=\"http://quote.eastmoney.com/unify/r/90.BK0473\" target=\"_blank\" web=\"1\">证券</span>日报》记者表示，在下沉市场的竞争中，茶百道对县镇消费者的吸引力是非常大的，很可能会对区域性品牌形成降维打击。</p> <p>　　根据弗若斯特沙利文的报告，2024年至2028年，二线城市、三线城市、四线及以下城市的现制茶饮店市场预计将分别以15.0%、18.0%、15.0%的年复合增长率进一步增长。种种数据表明，对于新茶饮企业而言，三线城市、四线及以下城市的市场规模和增长速度都极具吸引力。</p> <p>　　<strong>多家茶饮品牌拟IPO</strong></p> <p>　　据了解，除茶百道外，今年年初，古茗控股有限公司向港交所递交招股书，保荐人为<span><a href=\"https://laohu8.com/S/GS\">高盛</a></span><span></span>、瑞银。同一天，蜜雪冰城股份有限公司也向港交所递交招股书。今年3月份，沪上阿姨（上海）实业股份有限公司递表港交所。目前，上述3家茶饮企业仍处在审核阶段。</p> <p>　　晶捷互动创始人陈晶晶对《<span href=\"http://quote.eastmoney.com/unify/r/90.BK0473\" target=\"_blank\" web=\"1\">证券</span>日报》记者表示，在高端茶饮市场竞争格局基本已经固定的情况下，众多品牌提交上市申请，说明这些品牌急需借助资本市场的力量做大规模、做优产品、做实口碑，实现快速发展以应对可能到来的市场洗牌。</p> <p>　　中央财经大学副教授刘春生对《证券日报》记者表示，企业扎堆赴港上市说明尽管新茶饮备受资本关注，扩张速度快，但由于前期投入巨大，其盈利能力尚需市场检验，行业正处于快速发展和竞争激烈的阶段。对于企业来说，赴港上市可以拓宽融资渠道，提升品牌知名度和市场竞争力。</p> <p>　　除了已经在排队上市的企业外，也有新茶饮品牌传出上市计划。</p> <p>　　现制茶饮市场是中国饮品市场的重要组成部分，也是近年来最具活力和增长潜力的细分领域之一。据弗若斯特沙利文的数据，中国现制茶饮的规模从2018年的805亿元增长至2023年的2473亿元，预计到2028年将达到5385亿元，年均复合增长率为16.8%。</p><p>（文章来源：证券日报）</p> </div></body></html>","source":"stock_eastmoney","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>“新茶饮第二股”茶百道登陆港交所主板 多家茶饮品牌加速推进上市</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n“新茶饮第二股”茶百道登陆港交所主板 多家茶饮品牌加速推进上市\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-04-24 00:30 北京时间&nbsp;&nbsp;&nbsp;<a href=http://finance.eastmoney.com/a/202404243056352715.html><strong>证券日报</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>4月23日，新茶饮品牌“茶百道”母公司四川百茶百道实业股份有限公司（以下简称“茶百道”）正式于港交所主板挂牌。本次茶百道发行1.48亿股H股，发行价为每股17.50港元，募资总额高达25.9亿港元。 　　招股书显示，本次募集资金主要用于提高整体运营能力及强化供应链、发展数字化能力以及委聘和培训专业人才等。 　　中国企业资本联盟副理事长柏文喜对《证券日报》记者表示：“茶百道的上市不仅凸显了新茶饮市场...</p>\n\n<a href=\"http://finance.eastmoney.com/a/202404243056352715.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"02555":"茶百道"},"source_url":"http://finance.eastmoney.com/a/202404243056352715.html","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2429213117","content_text":"4月23日，新茶饮品牌“茶百道”母公司四川百茶百道实业股份有限公司（以下简称“茶百道”）正式于港交所主板挂牌。本次茶百道发行1.48亿股H股，发行价为每股17.50港元，募资总额高达25.9亿港元。 　　招股书显示，本次募集资金主要用于提高整体运营能力及强化供应链、发展数字化能力以及委聘和培训专业人才等。 　　中国企业资本联盟副理事长柏文喜对《证券日报》记者表示：“茶百道的上市不仅凸显了新茶饮市场的发展空间，还体现了资本市场对新茶饮行业的青睐。” 　　加速布局下沉市场 　　茶百道招股书显示，公司成立于2008年，首家门店开在成都。2021年至2023年，茶百道收入分别为36.44亿元、42.32亿元、57.04亿元，毛利分别为13.01亿元、14.56亿元、19.64亿元，同期毛利率分别为35.7%、34.4%及34.4%。 　　截至2024年4月5日，茶百道门店数已经达到8016家，实现所有省份及各线级城市的全覆盖。根据弗若斯特沙利文的报告，2023年，中国现制茶饮店市场规模为2473亿元。按零售额计，前五大参与者合共占据约40.2%的市场份额，茶百道以约6.8%的市场份额位居第三。 　　茶百道门店主要分布在新一线城市和二线城市，同时，三四线城市门店数量的占比也在提高。 　　招股书显示，到2023年底，茶百道门店在一线、新一线、二线、三线、四线及以下城市的数量占比分别为10.6%、26.9%、20.9%、19.4%及22.2%。茶百道称，低线级城市存在较大的市场空间，因此计划进一步在二线及以下的城市进行门店加密，抢占下沉市场。 　　中国食品产业研究院高级研究员朱丹蓬对《证券日报》记者表示，在下沉市场的竞争中，茶百道对县镇消费者的吸引力是非常大的，很可能会对区域性品牌形成降维打击。 　　根据弗若斯特沙利文的报告，2024年至2028年，二线城市、三线城市、四线及以下城市的现制茶饮店市场预计将分别以15.0%、18.0%、15.0%的年复合增长率进一步增长。种种数据表明，对于新茶饮企业而言，三线城市、四线及以下城市的市场规模和增长速度都极具吸引力。 　　多家茶饮品牌拟IPO 　　据了解，除茶百道外，今年年初，古茗控股有限公司向港交所递交招股书，保荐人为高盛、瑞银。同一天，蜜雪冰城股份有限公司也向港交所递交招股书。今年3月份，沪上阿姨（上海）实业股份有限公司递表港交所。目前，上述3家茶饮企业仍处在审核阶段。 　　晶捷互动创始人陈晶晶对《证券日报》记者表示，在高端茶饮市场竞争格局基本已经固定的情况下，众多品牌提交上市申请，说明这些品牌急需借助资本市场的力量做大规模、做优产品、做实口碑，实现快速发展以应对可能到来的市场洗牌。 　　中央财经大学副教授刘春生对《证券日报》记者表示，企业扎堆赴港上市说明尽管新茶饮备受资本关注，扩张速度快，但由于前期投入巨大，其盈利能力尚需市场检验，行业正处于快速发展和竞争激烈的阶段。对于企业来说，赴港上市可以拓宽融资渠道，提升品牌知名度和市场竞争力。 　　除了已经在排队上市的企业外，也有新茶饮品牌传出上市计划。 　　现制茶饮市场是中国饮品市场的重要组成部分，也是近年来最具活力和增长潜力的细分领域之一。据弗若斯特沙利文的数据，中国现制茶饮的规模从2018年的805亿元增长至2023年的2473亿元，预计到2028年将达到5385亿元，年均复合增长率为16.8%。（文章来源：证券日报）","news_type":1},"isVote":1,"tweetType":1,"viewCount":24,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":285745287102776,"gmtCreate":1710780485229,"gmtModify":1710780487194,"author":{"id":"3537417120281286","authorId":"3537417120281286","name":"小白土兔","avatar":"https://static.tigerbbs.com/ed03e24159cdfb1a1cc9e0eb75d70106","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"亿航开盘即巅峰，现在竟然能变成跌的，真的拉胯啊","listText":"亿航开盘即巅峰，现在竟然能变成跌的，真的拉胯啊","text":"亿航开盘即巅峰，现在竟然能变成跌的，真的拉胯啊","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/285745287102776","repostId":"1190618566","repostType":2,"repost":{"id":"1190618566","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1710762444,"share":"https://www.laohu8.com/m/news/1190618566?lang=&edition=full","pubTime":"2024-03-18 19:47","market":"us","language":"zh","title":"盘前 | 谷歌涨超5%！超微电脑、英伟达涨逾3%；“空中的士”淘宝开售，亿航智能涨超13%","url":"https://stock-news.laohu8.com/highlight/detail?id=1190618566","media":"老虎资讯综合","summary":"谷歌盘前涨超5%！首款国产“空中的士”淘宝开售！亿航智能盘前涨超13%今日全球首个获得适航认证的国产自研“空中的士”亿航EH216-S在淘宝上架，标价239万元。据悉，该“空中的士”为全智能无人驾驶航空器，可搭载两人，能够全智能低空飞行和垂直起降，完全不需要跑道。受此消息影响，亿航智能盘前涨超13%。$超微电脑$盘前涨近3%，今日起正式纳入标普指数。$小牛电动$盘前跌超3%，Q4营收同比下降21.8%。","content":"<html><head></head><body><p><strong>摘要：</strong></p><ul style=\"\"><li><p><a href=\"https://laohu8.com/S/NVDA\">英伟达</a>GTC大会重磅来袭，盘前股价涨近3%</p></li><li><p><a href=\"https://laohu8.com/S/GOOG\">谷歌</a>盘前涨超5%！报道：<a href=\"https://laohu8.com/S/AAPL\">苹果</a>正在谈判将谷歌的Gemini人工<a href=\"https://laohu8.com/S/5RE.SI\">智能</a>引擎植入iPhone</p></li><li><p><a href=\"https://laohu8.com/S/QCOM\">高通</a>推出第三代骁龙8s移动平台，支持终端侧生成式AI功能</p></li><li><p><a href=\"https://laohu8.com/S/SMCI\">超微电脑</a>今日起正式纳入标普指数</p></li><li><p><a href=\"https://laohu8.com/S/TSLA\">特斯拉</a>盘前涨超3%，宣布Model Y在欧洲多国提价</p></li><li><p>首款国产“空中的士”淘宝开售！<a href=\"https://laohu8.com/S/EH\">亿航智能</a>盘前涨超13%</p></li><li><p><a href=\"https://laohu8.com/S/PFE\">辉瑞</a>计划出售约6.3亿股<a href=\"https://laohu8.com/S/HLN\">Haleon</a>股票</p></li></ul><p>3月18日，美股三大股指期货上涨，截止发稿，道指期货涨0.12%，纳指期货涨1.10%，标普500指数期货涨0.69%。</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/032cdd1e5d59e72bcaaf50c56b8cd4e3\" title=\"\" tg-width=\"428\" tg-height=\"191\"/></p><h3 id=\"id_1214499721\">盘前要闻</h3><p><strong>英伟达GTC大会重磅来袭，盘前股价涨近3%</strong></p><p>3月18日-21日，英伟达AI大会GTC 2024将在美国圣何塞会议中心举行。今日（北京时间3月19日凌晨4点），英伟达CEO黄仁勋将进行主题为“面向开发者的1#AI峰会”演讲。据英伟达介绍，黄仁勋届时将发布加速计算、生成式AI以及<a href=\"https://laohu8.com/S/300024\">机器人</a>领域的最新突破性成果。</p><p>市场普遍认为，此次大会焦点有4个：1.下一代Blackwell GPU架构，2.新款B100芯片，3.人形机器人，4.AI+医药。华尔街预计，本届GTC将帮助英伟达股票结束近期的震荡走势，并继续保持今年迄今超过80%的强劲增长势头。</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/69f1ce094b052f65a9f51bf3c9462ad2\" title=\"\" tg-width=\"302\" tg-height=\"144\"/></p><p><strong>谷歌盘前涨超5%！报道：苹果正在谈判将谷歌的Gemini人工智能引擎植入iPhone</strong></p><p>据媒体援引知情人士消息，苹果与谷歌两家公司正在积极谈判，希望让苹果获得Gemini的授权，为今年iPhone软件的一些新功能提供支持。此外，苹果最近还与OpenAI进行讨论并考虑使用其模型。据报道，苹果希望获得相关许可，使用Gemini模型为iOS 18加入全新生成式AI功能。此前报道指出，分析师Mark Gurman透露，即将在今年6月发布的iOS 18，将会是苹果iOS史上最大更新，而其更新的关键就是围绕“AI”展开。</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/73b10c8ad885885b2ef5f3dba1ca9b36\" title=\"\" tg-width=\"299\" tg-height=\"152\"/></p><p><strong>首款国产“空中的士”淘宝开售！亿航智能盘前涨超13%</strong></p><p>今日全球首个获得适航认证的国产自研“空中的士”亿航EH216-S在淘宝上架，标价239万元。据悉，该“空中的士”为全智能无人驾驶航空器，可搭载两人，能够全智能低空飞行和垂直起降，完全不需要跑道。行业人士分析，作为新质生产力的代表，低空经济正走向落地普惠的阶段，“空中的士”的上架迈出了向低空自由飞行的坚实一步。受此消息影响，亿航智能盘前涨超13%。</p><p><strong>高通推出第三代骁龙8s移动平台，支持终端侧生成式AI功能</strong></p><p>北京时间3月18日下午，高通宣布推出全新的第三代骁龙8s移动平台，该平台将具备终端侧生成式AI功能以及始终感知的ISP。高通方面表示，骁龙8s平台支持绝大部分主流AI模型，包括百川智能的Baichuan-7B、谷歌旗下的Gemini Nano、Meta旗下的Llama 2和智谱ChatGLM等。受此消息影响，高通盘前涨超1%。</p><p><strong>辉瑞计划出售约6.3亿股Haleon股票</strong></p><p>英国消费保健巨头Haleon周一表示，辉瑞将出售其在该公司的约6.3亿股股份，将其持股减少到24%左右。辉瑞目前持有Haleon的32%股份，该公司去年5月宣布，计划在几个月内以“缓慢而有条理”的方式减持股权。Haleon在一份声明中表示，辉瑞出售其股份的价格预计将在3月19日左右公布，届时将完成簿记程序。</p><p><strong><a href=\"https://laohu8.com/S/F\">福特汽车</a>据称正开发一款售价2.5万美元的紧凑型电动车</strong></p><p>消息人士：福特汽车据称正在开发一款售价为2.5万美元的紧凑型电动车，预计将于2026年底首次亮相。福特汽车新的电动车平台将采用更便宜的锂铁磷酸(LFP)电池。福特汽车紧凑型车型是三款新的低成本电动车之一。</p><h3 id=\"id_3415585353\">盘前行情</h3><p>特斯拉(TSLA)$盘前涨超3%，宣布Model Y在欧洲多国提价2000欧元。当地时间上周六，<a href=\"https://laohu8.com/S/TSLA\">特斯拉</a>在X平台的官方账号宣布，将于3月22日在多个欧洲国家提高其Model Y电动汽车的价格，涨幅约为2000欧元(约2177美元)，或当地货币等值。此前一天，特斯拉宣布从4月1日起，将在美国销售的Model Y价格上调1000美元。这将是特斯拉Model Y一个月内第二次提价。3月1日，特斯拉已将Model Y后轮驱动版和远程版的价格分别提高了1000美元，至43990美元和48990美元。</p><p><a href=\"https://laohu8.com/S/SMCI\">超微电脑</a>盘前涨近3%，今日起正式纳入标普指数。</p><p>部分中概股上涨，<a href=\"https://laohu8.com/S/XPEV\">小鹏汽车</a>涨超6%，<a href=\"https://laohu8.com/S/NIO\">蔚来</a>涨超4%，<a href=\"https://laohu8.com/S/BILI\">哔哩哔哩</a>、<a href=\"https://laohu8.com/S/PDD\">拼多多</a>涨超2%。</p><p><a href=\"https://laohu8.com/S/LI\">理想汽车</a>盘前跌超5%，“MEGA”据报订单逊预期，管理层考虑下调销售目标。</p><p><a href=\"https://laohu8.com/S/HLN\">Haleon</a>盘前跌超1%，<a href=\"https://laohu8.com/S/PFE\">辉瑞</a>计划出售约6.3亿股<a href=\"https://laohu8.com/S/HLN\">Haleon</a>股票。</p><p><a href=\"https://laohu8.com/S/NIU\">小牛电动</a>盘前跌超3%，Q4营收同比下降21.8%。</p><p><a href=\"https://laohu8.com/S/LOGI\">罗技</a>股价盘前跌近6%，公司首席财务官辞职。</p><p>Shift4盘前跌超8%，公司CEO称潜在收购出价未充分反映价值。</p><h3 id=\"id_1154522510\">欧洲市场</h3><p>欧洲主要指数涨多跌少，德国DAX30涨0.36%，法国CAC40涨0.18%。</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/f2dbb9a82bf17cc786ea9c6de70cb5a9\" title=\"\" tg-width=\"1431\" tg-height=\"565\"/></p><h3 id=\"id_2405271039\">原油</h3><p>国际油价上涨，美油报81.09美元/桶，日内涨幅0.63%；布油现报85.80美元/桶，日内涨幅0.54%。</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/196fba7701318c85bdefd6a1b3424937\" title=\"\" tg-width=\"1415\" tg-height=\"90\"/></p><h3 id=\"id_89612189\">黄金</h3><p>现货黄金日内涨0.12%，报2,163.85美元/盎司。</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/50fe7834a761630db4d0282ac207cf48\" title=\"\" tg-width=\"560\" tg-height=\"240\"/></p><p></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>盘前 | 谷歌涨超5%！超微电脑、英伟达涨逾3%；“空中的士”淘宝开售，亿航智能涨超13%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n盘前 | 谷歌涨超5%！超微电脑、英伟达涨逾3%；“空中的士”淘宝开售，亿航智能涨超13%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2024-03-18 19:47</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p><strong>摘要：</strong></p><ul style=\"\"><li><p><a href=\"https://laohu8.com/S/NVDA\">英伟达</a>GTC大会重磅来袭，盘前股价涨近3%</p></li><li><p><a href=\"https://laohu8.com/S/GOOG\">谷歌</a>盘前涨超5%！报道：<a href=\"https://laohu8.com/S/AAPL\">苹果</a>正在谈判将谷歌的Gemini人工<a href=\"https://laohu8.com/S/5RE.SI\">智能</a>引擎植入iPhone</p></li><li><p><a href=\"https://laohu8.com/S/QCOM\">高通</a>推出第三代骁龙8s移动平台，支持终端侧生成式AI功能</p></li><li><p><a href=\"https://laohu8.com/S/SMCI\">超微电脑</a>今日起正式纳入标普指数</p></li><li><p><a href=\"https://laohu8.com/S/TSLA\">特斯拉</a>盘前涨超3%，宣布Model Y在欧洲多国提价</p></li><li><p>首款国产“空中的士”淘宝开售！<a href=\"https://laohu8.com/S/EH\">亿航智能</a>盘前涨超13%</p></li><li><p><a href=\"https://laohu8.com/S/PFE\">辉瑞</a>计划出售约6.3亿股<a href=\"https://laohu8.com/S/HLN\">Haleon</a>股票</p></li></ul><p>3月18日，美股三大股指期货上涨，截止发稿，道指期货涨0.12%，纳指期货涨1.10%，标普500指数期货涨0.69%。</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/032cdd1e5d59e72bcaaf50c56b8cd4e3\" title=\"\" tg-width=\"428\" tg-height=\"191\"/></p><h3 id=\"id_1214499721\">盘前要闻</h3><p><strong>英伟达GTC大会重磅来袭，盘前股价涨近3%</strong></p><p>3月18日-21日，英伟达AI大会GTC 2024将在美国圣何塞会议中心举行。今日（北京时间3月19日凌晨4点），英伟达CEO黄仁勋将进行主题为“面向开发者的1#AI峰会”演讲。据英伟达介绍，黄仁勋届时将发布加速计算、生成式AI以及<a href=\"https://laohu8.com/S/300024\">机器人</a>领域的最新突破性成果。</p><p>市场普遍认为，此次大会焦点有4个：1.下一代Blackwell GPU架构，2.新款B100芯片，3.人形机器人，4.AI+医药。华尔街预计，本届GTC将帮助英伟达股票结束近期的震荡走势，并继续保持今年迄今超过80%的强劲增长势头。</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/69f1ce094b052f65a9f51bf3c9462ad2\" title=\"\" tg-width=\"302\" tg-height=\"144\"/></p><p><strong>谷歌盘前涨超5%！报道：苹果正在谈判将谷歌的Gemini人工智能引擎植入iPhone</strong></p><p>据媒体援引知情人士消息，苹果与谷歌两家公司正在积极谈判，希望让苹果获得Gemini的授权，为今年iPhone软件的一些新功能提供支持。此外，苹果最近还与OpenAI进行讨论并考虑使用其模型。据报道，苹果希望获得相关许可，使用Gemini模型为iOS 18加入全新生成式AI功能。此前报道指出，分析师Mark Gurman透露，即将在今年6月发布的iOS 18，将会是苹果iOS史上最大更新，而其更新的关键就是围绕“AI”展开。</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/73b10c8ad885885b2ef5f3dba1ca9b36\" title=\"\" tg-width=\"299\" tg-height=\"152\"/></p><p><strong>首款国产“空中的士”淘宝开售！亿航智能盘前涨超13%</strong></p><p>今日全球首个获得适航认证的国产自研“空中的士”亿航EH216-S在淘宝上架，标价239万元。据悉，该“空中的士”为全智能无人驾驶航空器，可搭载两人，能够全智能低空飞行和垂直起降，完全不需要跑道。行业人士分析，作为新质生产力的代表，低空经济正走向落地普惠的阶段，“空中的士”的上架迈出了向低空自由飞行的坚实一步。受此消息影响，亿航智能盘前涨超13%。</p><p><strong>高通推出第三代骁龙8s移动平台，支持终端侧生成式AI功能</strong></p><p>北京时间3月18日下午，高通宣布推出全新的第三代骁龙8s移动平台，该平台将具备终端侧生成式AI功能以及始终感知的ISP。高通方面表示，骁龙8s平台支持绝大部分主流AI模型，包括百川智能的Baichuan-7B、谷歌旗下的Gemini Nano、Meta旗下的Llama 2和智谱ChatGLM等。受此消息影响，高通盘前涨超1%。</p><p><strong>辉瑞计划出售约6.3亿股Haleon股票</strong></p><p>英国消费保健巨头Haleon周一表示，辉瑞将出售其在该公司的约6.3亿股股份，将其持股减少到24%左右。辉瑞目前持有Haleon的32%股份，该公司去年5月宣布，计划在几个月内以“缓慢而有条理”的方式减持股权。Haleon在一份声明中表示，辉瑞出售其股份的价格预计将在3月19日左右公布，届时将完成簿记程序。</p><p><strong><a href=\"https://laohu8.com/S/F\">福特汽车</a>据称正开发一款售价2.5万美元的紧凑型电动车</strong></p><p>消息人士：福特汽车据称正在开发一款售价为2.5万美元的紧凑型电动车，预计将于2026年底首次亮相。福特汽车新的电动车平台将采用更便宜的锂铁磷酸(LFP)电池。福特汽车紧凑型车型是三款新的低成本电动车之一。</p><h3 id=\"id_3415585353\">盘前行情</h3><p>特斯拉(TSLA)$盘前涨超3%，宣布Model Y在欧洲多国提价2000欧元。当地时间上周六，<a href=\"https://laohu8.com/S/TSLA\">特斯拉</a>在X平台的官方账号宣布，将于3月22日在多个欧洲国家提高其Model Y电动汽车的价格，涨幅约为2000欧元(约2177美元)，或当地货币等值。此前一天，特斯拉宣布从4月1日起，将在美国销售的Model Y价格上调1000美元。这将是特斯拉Model Y一个月内第二次提价。3月1日，特斯拉已将Model Y后轮驱动版和远程版的价格分别提高了1000美元，至43990美元和48990美元。</p><p><a href=\"https://laohu8.com/S/SMCI\">超微电脑</a>盘前涨近3%，今日起正式纳入标普指数。</p><p>部分中概股上涨，<a href=\"https://laohu8.com/S/XPEV\">小鹏汽车</a>涨超6%，<a href=\"https://laohu8.com/S/NIO\">蔚来</a>涨超4%，<a href=\"https://laohu8.com/S/BILI\">哔哩哔哩</a>、<a href=\"https://laohu8.com/S/PDD\">拼多多</a>涨超2%。</p><p><a href=\"https://laohu8.com/S/LI\">理想汽车</a>盘前跌超5%，“MEGA”据报订单逊预期，管理层考虑下调销售目标。</p><p><a href=\"https://laohu8.com/S/HLN\">Haleon</a>盘前跌超1%，<a href=\"https://laohu8.com/S/PFE\">辉瑞</a>计划出售约6.3亿股<a href=\"https://laohu8.com/S/HLN\">Haleon</a>股票。</p><p><a href=\"https://laohu8.com/S/NIU\">小牛电动</a>盘前跌超3%，Q4营收同比下降21.8%。</p><p><a href=\"https://laohu8.com/S/LOGI\">罗技</a>股价盘前跌近6%，公司首席财务官辞职。</p><p>Shift4盘前跌超8%，公司CEO称潜在收购出价未充分反映价值。</p><h3 id=\"id_1154522510\">欧洲市场</h3><p>欧洲主要指数涨多跌少，德国DAX30涨0.36%，法国CAC40涨0.18%。</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/f2dbb9a82bf17cc786ea9c6de70cb5a9\" title=\"\" tg-width=\"1431\" tg-height=\"565\"/></p><h3 id=\"id_2405271039\">原油</h3><p>国际油价上涨，美油报81.09美元/桶，日内涨幅0.63%；布油现报85.80美元/桶，日内涨幅0.54%。</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/196fba7701318c85bdefd6a1b3424937\" title=\"\" tg-width=\"1415\" tg-height=\"90\"/></p><h3 id=\"id_89612189\">黄金</h3><p>现货黄金日内涨0.12%，报2,163.85美元/盎司。</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/50fe7834a761630db4d0282ac207cf48\" title=\"\" tg-width=\"560\" tg-height=\"240\"/></p><p></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/ed4ee39e6b0f45214393093d70ba81a8","relate_stocks":{"BK4588":"碎股","BK4551":"寇图资本持仓","LU0039217434.USD":"HSBC GIF CHINESE EQUITY \"AD\" INC","SMCI":"超微电脑","LU0106959298.USD":"UBS (LUX) EQUITY FUND - EMERGING MARKETS SUSTAINABLE LEADERS (USD) \"P\" (USD) ACC","LU0229945570.USD":"TEMPLETON BRIC \"A\" (USD) ACC","EH":"亿航智能","LU0320764599.SGD":"FTIF - Templeton China A Acc SGD","LU0052750758.USD":"富兰克林中国基金A Acc","LU1046422090.SGD":"Fidelity Pacific A-SGD","LU0289941410.SGD":"AB FCP I Dynamic Diversified AX SGD","BK4579":"人工智能","LU0965509101.SGD":"AB LOW VOLATILITY EQUITY PORTFOLIO \"A\" (SGDHDG) ACC","LU0256863811.USD":"ALLIANZ US EQUITY \"A\" INC","LU1316542783.SGD":"Janus Henderson Horizon Global Technology Leaders A2 SGD","NVDA":"英伟达","BK4550":"红杉资本持仓","BABA":"阿里巴巴","TSLA":"特斯拉","09988":"阿里巴巴-SW","GOOGL":"谷歌A","GOOG":"谷歌"},"source_url":"","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1190618566","content_text":"摘要：英伟达GTC大会重磅来袭，盘前股价涨近3%谷歌盘前涨超5%！报道：苹果正在谈判将谷歌的Gemini人工智能引擎植入iPhone高通推出第三代骁龙8s移动平台，支持终端侧生成式AI功能超微电脑今日起正式纳入标普指数特斯拉盘前涨超3%，宣布Model Y在欧洲多国提价首款国产“空中的士”淘宝开售！亿航智能盘前涨超13%辉瑞计划出售约6.3亿股Haleon股票3月18日，美股三大股指期货上涨，截止发稿，道指期货涨0.12%，纳指期货涨1.10%，标普500指数期货涨0.69%。盘前要闻英伟达GTC大会重磅来袭，盘前股价涨近3%3月18日-21日，英伟达AI大会GTC 2024将在美国圣何塞会议中心举行。今日（北京时间3月19日凌晨4点），英伟达CEO黄仁勋将进行主题为“面向开发者的1#AI峰会”演讲。据英伟达介绍，黄仁勋届时将发布加速计算、生成式AI以及机器人领域的最新突破性成果。市场普遍认为，此次大会焦点有4个：1.下一代Blackwell GPU架构，2.新款B100芯片，3.人形机器人，4.AI+医药。华尔街预计，本届GTC将帮助英伟达股票结束近期的震荡走势，并继续保持今年迄今超过80%的强劲增长势头。谷歌盘前涨超5%！报道：苹果正在谈判将谷歌的Gemini人工智能引擎植入iPhone据媒体援引知情人士消息，苹果与谷歌两家公司正在积极谈判，希望让苹果获得Gemini的授权，为今年iPhone软件的一些新功能提供支持。此外，苹果最近还与OpenAI进行讨论并考虑使用其模型。据报道，苹果希望获得相关许可，使用Gemini模型为iOS 18加入全新生成式AI功能。此前报道指出，分析师Mark Gurman透露，即将在今年6月发布的iOS 18，将会是苹果iOS史上最大更新，而其更新的关键就是围绕“AI”展开。首款国产“空中的士”淘宝开售！亿航智能盘前涨超13%今日全球首个获得适航认证的国产自研“空中的士”亿航EH216-S在淘宝上架，标价239万元。据悉，该“空中的士”为全智能无人驾驶航空器，可搭载两人，能够全智能低空飞行和垂直起降，完全不需要跑道。行业人士分析，作为新质生产力的代表，低空经济正走向落地普惠的阶段，“空中的士”的上架迈出了向低空自由飞行的坚实一步。受此消息影响，亿航智能盘前涨超13%。高通推出第三代骁龙8s移动平台，支持终端侧生成式AI功能北京时间3月18日下午，高通宣布推出全新的第三代骁龙8s移动平台，该平台将具备终端侧生成式AI功能以及始终感知的ISP。高通方面表示，骁龙8s平台支持绝大部分主流AI模型，包括百川智能的Baichuan-7B、谷歌旗下的Gemini Nano、Meta旗下的Llama 2和智谱ChatGLM等。受此消息影响，高通盘前涨超1%。辉瑞计划出售约6.3亿股Haleon股票英国消费保健巨头Haleon周一表示，辉瑞将出售其在该公司的约6.3亿股股份，将其持股减少到24%左右。辉瑞目前持有Haleon的32%股份，该公司去年5月宣布，计划在几个月内以“缓慢而有条理”的方式减持股权。Haleon在一份声明中表示，辉瑞出售其股份的价格预计将在3月19日左右公布，届时将完成簿记程序。福特汽车据称正开发一款售价2.5万美元的紧凑型电动车消息人士：福特汽车据称正在开发一款售价为2.5万美元的紧凑型电动车，预计将于2026年底首次亮相。福特汽车新的电动车平台将采用更便宜的锂铁磷酸(LFP)电池。福特汽车紧凑型车型是三款新的低成本电动车之一。盘前行情特斯拉(TSLA)$盘前涨超3%，宣布Model Y在欧洲多国提价2000欧元。当地时间上周六，特斯拉在X平台的官方账号宣布，将于3月22日在多个欧洲国家提高其Model Y电动汽车的价格，涨幅约为2000欧元(约2177美元)，或当地货币等值。此前一天，特斯拉宣布从4月1日起，将在美国销售的Model Y价格上调1000美元。这将是特斯拉Model Y一个月内第二次提价。3月1日，特斯拉已将Model Y后轮驱动版和远程版的价格分别提高了1000美元，至43990美元和48990美元。超微电脑盘前涨近3%，今日起正式纳入标普指数。部分中概股上涨，小鹏汽车涨超6%，蔚来涨超4%，哔哩哔哩、拼多多涨超2%。理想汽车盘前跌超5%，“MEGA”据报订单逊预期，管理层考虑下调销售目标。Haleon盘前跌超1%，辉瑞计划出售约6.3亿股Haleon股票。小牛电动盘前跌超3%，Q4营收同比下降21.8%。罗技股价盘前跌近6%，公司首席财务官辞职。Shift4盘前跌超8%，公司CEO称潜在收购出价未充分反映价值。欧洲市场欧洲主要指数涨多跌少，德国DAX30涨0.36%，法国CAC40涨0.18%。原油国际油价上涨，美油报81.09美元/桶，日内涨幅0.63%；布油现报85.80美元/桶，日内涨幅0.54%。黄金现货黄金日内涨0.12%，报2,163.85美元/盎司。","news_type":1},"isVote":1,"tweetType":1,"viewCount":108,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":283941172039760,"gmtCreate":1710338046315,"gmtModify":1710338047959,"author":{"id":"3537417120281286","authorId":"3537417120281286","name":"小白土兔","avatar":"https://static.tigerbbs.com/ed03e24159cdfb1a1cc9e0eb75d70106","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"都熄火了","listText":"都熄火了","text":"都熄火了","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/283941172039760","isVote":1,"tweetType":1,"viewCount":347,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":283881180807400,"gmtCreate":1710323269233,"gmtModify":1710323270888,"author":{"id":"3537417120281286","authorId":"3537417120281286","name":"小白土兔","avatar":"https://static.tigerbbs.com/ed03e24159cdfb1a1cc9e0eb75d70106","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"又开始炒作中概股，缺韭菜了吧","listText":"又开始炒作中概股，缺韭菜了吧","text":"又开始炒作中概股，缺韭菜了吧","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/283881180807400","isVote":1,"tweetType":1,"viewCount":159,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":283880662966360,"gmtCreate":1710323142671,"gmtModify":1710323245470,"author":{"id":"3537417120281286","authorId":"3537417120281286","name":"小白土兔","avatar":"https://static.tigerbbs.com/ed03e24159cdfb1a1cc9e0eb75d70106","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"和朋友聊到我在美股的中概股亏了很多钱，他说，人家中国企业不远万里是想着去割外国资本主义的韭菜，你倒好，非要跑去让人家割，被大a割的还不够吗？你亏了活该。 从此再也不碰中概股。中概股玩法和a股一样，没有武德，没有价值投资，中国人就别去被骗了吧","listText":"和朋友聊到我在美股的中概股亏了很多钱，他说，人家中国企业不远万里是想着去割外国资本主义的韭菜，你倒好，非要跑去让人家割，被大a割的还不够吗？你亏了活该。 从此再也不碰中概股。中概股玩法和a股一样，没有武德，没有价值投资，中国人就别去被骗了吧","text":"和朋友聊到我在美股的中概股亏了很多钱，他说，人家中国企业不远万里是想着去割外国资本主义的韭菜，你倒好，非要跑去让人家割，被大a割的还不够吗？你亏了活该。 从此再也不碰中概股。中概股玩法和a股一样，没有武德，没有价值投资，中国人就别去被骗了吧","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/283880662966360","isVote":1,"tweetType":1,"viewCount":172,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":283370305646904,"gmtCreate":1710210667536,"gmtModify":1710210669608,"author":{"id":"3537417120281286","authorId":"3537417120281286","name":"小白土兔","avatar":"https://static.tigerbbs.com/ed03e24159cdfb1a1cc9e0eb75d70106","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"中概股和大a一样，先腰斩再腰斩，然后疯涨20%哈哈哈哈。然后就说狂欢了。","listText":"中概股和大a一样，先腰斩再腰斩，然后疯涨20%哈哈哈哈。然后就说狂欢了。","text":"中概股和大a一样，先腰斩再腰斩，然后疯涨20%哈哈哈哈。然后就说狂欢了。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/283370305646904","isVote":1,"tweetType":1,"viewCount":568,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":256335410282784,"gmtCreate":1703601069202,"gmtModify":1703601070119,"author":{"id":"3537417120281286","authorId":"3537417120281286","name":"小白土兔","avatar":"https://static.tigerbbs.com/ed03e24159cdfb1a1cc9e0eb75d70106","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/IOVA\">$Iovance Biotherapeutics, Inc.(IOVA)$&nbsp;</a>你啥时候也被收购啊","listText":"<a href=\"https://laohu8.com/S/IOVA\">$Iovance Biotherapeutics, Inc.(IOVA)$&nbsp;</a>你啥时候也被收购啊","text":"$Iovance Biotherapeutics, Inc.(IOVA)$ 你啥时候也被收购啊","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/256335410282784","isVote":1,"tweetType":1,"viewCount":672,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":236468400689360,"gmtCreate":1698764311639,"gmtModify":1698764313059,"author":{"id":"3537417120281286","authorId":"3537417120281286","name":"小白土兔","avatar":"https://static.tigerbbs.com/ed03e24159cdfb1a1cc9e0eb75d70106","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"生存率好低啊","listText":"生存率好低啊","text":"生存率好低啊","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/236468400689360","repostId":"2379329541","repostType":2,"repost":{"id":"2379329541","weMediaInfo":{"introduction":"Share your news with media, investors, and consumers with targeted distribution options from one of the world’s largest and most trusted newswires.","home_visible":1,"media_name":"GlobeNewswire","id":"1016364462","head_image":"https://static.tigerbbs.com/31bb960c88eab45f27ccc9fce75dee9a"},"pubTimestamp":1698728700,"share":"https://www.laohu8.com/m/news/2379329541?lang=&edition=full","pubTime":"2023-10-31 13:05","market":"us","language":"en","title":"Iovance Biotherapeutics to Present Clinical and Pre-Clinical Data for Tumor Infiltrating Lymphocyte (TIL) Therapies at Society for Tumor Immunotherapy of Cancer’s (SITC) 38th Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2379329541","media":"GlobeNewswire","summary":"SAN CARLOS, Calif., Oct.  31, 2023  (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor i","content":"<html><body><p>SAN CARLOS, Calif., Oct.  31, 2023  (GLOBE NEWSWIRE) -- <a href=\"https://laohu8.com/S/IOVA\">Iovance Biotherapeutics, Inc.</a> (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer, today announced the publication of abstracts for poster presentations reporting clinical data and trial design for tumor infiltrating lymphocyte (TIL) therapies at the Society for Immunotherapy of Cancer’s (SITC) 38<sup>th</sup> Annual Meeting in San Diego, CA, November 1-5, 2023.<br/></p> <p>An abstract on the four-year analysis of pooled Cohorts 2 and 4 of the C-144-01 trial reports the longest follow-up data on lifileucel treatment outcomes in the largest population of patients with anti–PD-1–refractory advanced melanoma treated with TIL therapy. As of the data cutoff date of June 16, 2023, median C-144-01 trial follow-up was 48.1 months in heavily pretreated patients with advanced melanoma. One-time lifileucel TIL therapy demonstrated durable efficacy with a four-year OS rate of 22.2%. The longest response was ongoing at 59.9 months. Treatment-emergent adverse events were consistent with known safety profiles of lymphodepletion and IL-2, and their incidence decreased over time. The four-year analysis further supports the use of lifileucel as a potential treatment option in these patients that is differentiated from other immunotherapies.</p> <p><strong>Iovance Posters at SITC Annual Meeting</strong></p> <ul type=\"disc\"><li>Long-term efficacy and safety of lifileucel tumor infiltrating lymphocyte (TIL) cell therapy in patients with advanced melanoma: A 4-year analysis of the C-144-01 study <ul type=\"circle\"><li>Poster: Saturday, Nov. 4, 2023, 9:00 a.m.–8:30 p.m. PT</li></ul> </li><li>Tumor infiltrating lymphocytes (TIL) with inducible and membrane-bound IL-12 exhibit superior antitumor activity <em>in vitro</em> <ul type=\"circle\"><li>Poster: Friday, Nov. 3, 2023, 9:00 a.m.–7:00 p.m. PT</li></ul> </li><li>Trial-in-Progress: TILVANCE-301, a phase 3 study of lifileucel tumor infiltrating lymphocyte (TIL) cell therapy combined with pembrolizumab (pembro) vs pembro alone in treatment-naïve unresectable or metastatic melanoma <ul type=\"circle\"><li>Poster: Saturday, Nov. 4, 2023, 9:00 a.m.–8:30 p.m. PT</li></ul> </li></ul> <p><strong>About Iovance Biotherapeutics, Inc.</strong><br/>Iovance Biotherapeutics aims to be the global leader in innovating, developing and delivering tumor infiltrating lymphocyte (TIL) therapies for patients with cancer. We are pioneering a transformational approach to cure cancer by harnessing the human immune system’s ability to recognize and destroy diverse cancer cells in each patient. Our lead late-stage TIL product candidate, lifileucel for metastatic melanoma, has the potential to become the first approved one-time cell therapy for a solid tumor cancer. The Iovance TIL platform has demonstrated promising clinical data across multiple solid tumors. We are committed to continuous innovation in cell therapy, including gene-edited cell therapy, that may extend and improve life for patients with cancer. For more information, please visit www.iovance.com.</p> <p><strong>Forward-Looking Statements</strong><br/>Certain matters discussed in this press release are “forward-looking statements” of Iovance Biotherapeutics, Inc. (hereinafter referred to as the “Company,” “we,” “us,” or “our”) within the meaning of the Private Securities Litigation Reform Act of 1995 (the “PSLRA”). All such written or oral statements made in this press release, other than statements of historical fact, are forward-looking statements and are intended to be covered by the safe harbor for forward-looking statements provided by the PSLRA. Without limiting the foregoing, we may, in some cases, use terms such as “predicts,” “believes,” “potential,” “continue,” “estimates,” “anticipates,” “expects,” “plans,” “intends,” “forecast,” “guidance,” “outlook,” “may,” “could,” “might,” “will,” “should” or other words that convey uncertainty of future events or outcomes and are intended to identify forward-looking statements. Forward-looking statements are based on assumptions and assessments made in light of management’s experience and perception of historical trends, current conditions, expected future developments and other factors believed to be appropriate. Forward-looking statements in this press release are made as of the date of this press release, and we undertake no duty to update or revise any such statements, whether as a result of new information, future events or otherwise. Forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and other factors, many of which are outside of our control, that may cause actual results, levels of activity, performance, achievements and developments to be materially different from those expressed in or implied by these forward-looking statements. Important factors that could cause actual results, developments and business decisions to differ materially from forward-looking statements are described in the sections titled \"Risk Factors\" in our filings with the Securities and Exchange Commission, including our most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, and include, but are not limited to, the following substantial known and unknown risks and uncertainties inherent in our business: the effects of the COVID-19 pandemic; risks related to the timing of and our ability to successfully develop, submit, obtain and maintain U.S. Food and Drug Administration (“FDA”) or other regulatory authority approval of, or other action with respect to, our product candidates, and our ability to successfully commercialize any product candidates for which we obtain FDA approval; whether clinical trial results from our pivotal studies and cohorts, and meetings with the FDA, may support registrational studies and subsequent approvals by the FDA; preliminary and interim clinical results, which may include efficacy and safety results, from ongoing clinical trials or cohorts may not be reflected in the final analyses of our ongoing clinical trials or subgroups within these trials or in other prior trials or cohorts; the risk that enrollment may need to be adjusted for our trials and cohorts within those trials based on FDA and other regulatory agency input; the changing landscape of care for cervical cancer patients may impact our clinical trials in this indication; the risk that we may be required to conduct additional clinical trials or modify ongoing or future clinical trials based on feedback from the FDA or other regulatory authorities; the risk that our interpretation of the results of our clinical trials or communications with the FDA may differ from the interpretation of such results or communications by the FDA (including from the prior pre-BLA meeting with the FDA); the risk that the FDA may not approve or may delay approval for our BLA submission for lifileucel in metastatic melanoma; the acceptance by the market of our product candidates and their potential reimbursement by payors, if approved; our ability or inability to manufacture our therapies using third party manufacturers or our own facility may adversely affect our potential commercial launch; the results of clinical trials with collaborators using different manufacturing processes may not be reflected in our sponsored trials; the risk that unanticipated expenses may decrease our estimated cash balances and forecasts and increase our estimated capital requirements; and other factors, including general economic conditions and regulatory developments, not within our control.</p> <p><strong>CONTACTS</strong><br/><strong>Iovance Biotherapeutics, Inc</strong>:<br/>Sara Pellegrino, IRC<br/>Senior Vice President, Investor Relations &amp; Corporate Communications<br/>650-260-7120 ext. 264<br/>Sara.Pellegrino@iovance.com</p> <p>Jen Saunders<br/>Director, Investor Relations &amp; Public Relations<br/>267-485-3119<br/>Jen.Saunders@iovance.com</p> <br/><img referrerpolicy=\"no-referrer-when-downgrade\" src=\"https://ml.globenewswire.com/media/MmM1YmZiZjYtNzNkYi00ZDgyLWE3ODgtZmYyMzUwOGVjOWJhLTEwMzA3Njk=/tiny/Iovance-Biotherapeutics-Inc.png\"/></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Iovance Biotherapeutics to Present Clinical and Pre-Clinical Data for Tumor Infiltrating Lymphocyte (TIL) Therapies at Society for Tumor Immunotherapy of Cancer’s (SITC) 38th Annual Meeting</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIovance Biotherapeutics to Present Clinical and Pre-Clinical Data for Tumor Infiltrating Lymphocyte (TIL) Therapies at Society for Tumor Immunotherapy of Cancer’s (SITC) 38th Annual Meeting\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1016364462\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/31bb960c88eab45f27ccc9fce75dee9a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">GlobeNewswire </p>\n<p class=\"h-time\">2023-10-31 13:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>SAN CARLOS, Calif., Oct.  31, 2023  (GLOBE NEWSWIRE) -- <a href=\"https://laohu8.com/S/IOVA\">Iovance Biotherapeutics, Inc.</a> (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer, today announced the publication of abstracts for poster presentations reporting clinical data and trial design for tumor infiltrating lymphocyte (TIL) therapies at the Society for Immunotherapy of Cancer’s (SITC) 38<sup>th</sup> Annual Meeting in San Diego, CA, November 1-5, 2023.<br/></p> <p>An abstract on the four-year analysis of pooled Cohorts 2 and 4 of the C-144-01 trial reports the longest follow-up data on lifileucel treatment outcomes in the largest population of patients with anti–PD-1–refractory advanced melanoma treated with TIL therapy. As of the data cutoff date of June 16, 2023, median C-144-01 trial follow-up was 48.1 months in heavily pretreated patients with advanced melanoma. One-time lifileucel TIL therapy demonstrated durable efficacy with a four-year OS rate of 22.2%. The longest response was ongoing at 59.9 months. Treatment-emergent adverse events were consistent with known safety profiles of lymphodepletion and IL-2, and their incidence decreased over time. The four-year analysis further supports the use of lifileucel as a potential treatment option in these patients that is differentiated from other immunotherapies.</p> <p><strong>Iovance Posters at SITC Annual Meeting</strong></p> <ul type=\"disc\"><li>Long-term efficacy and safety of lifileucel tumor infiltrating lymphocyte (TIL) cell therapy in patients with advanced melanoma: A 4-year analysis of the C-144-01 study <ul type=\"circle\"><li>Poster: Saturday, Nov. 4, 2023, 9:00 a.m.–8:30 p.m. PT</li></ul> </li><li>Tumor infiltrating lymphocytes (TIL) with inducible and membrane-bound IL-12 exhibit superior antitumor activity <em>in vitro</em> <ul type=\"circle\"><li>Poster: Friday, Nov. 3, 2023, 9:00 a.m.–7:00 p.m. PT</li></ul> </li><li>Trial-in-Progress: TILVANCE-301, a phase 3 study of lifileucel tumor infiltrating lymphocyte (TIL) cell therapy combined with pembrolizumab (pembro) vs pembro alone in treatment-naïve unresectable or metastatic melanoma <ul type=\"circle\"><li>Poster: Saturday, Nov. 4, 2023, 9:00 a.m.–8:30 p.m. PT</li></ul> </li></ul> <p><strong>About Iovance Biotherapeutics, Inc.</strong><br/>Iovance Biotherapeutics aims to be the global leader in innovating, developing and delivering tumor infiltrating lymphocyte (TIL) therapies for patients with cancer. We are pioneering a transformational approach to cure cancer by harnessing the human immune system’s ability to recognize and destroy diverse cancer cells in each patient. Our lead late-stage TIL product candidate, lifileucel for metastatic melanoma, has the potential to become the first approved one-time cell therapy for a solid tumor cancer. The Iovance TIL platform has demonstrated promising clinical data across multiple solid tumors. We are committed to continuous innovation in cell therapy, including gene-edited cell therapy, that may extend and improve life for patients with cancer. For more information, please visit www.iovance.com.</p> <p><strong>Forward-Looking Statements</strong><br/>Certain matters discussed in this press release are “forward-looking statements” of Iovance Biotherapeutics, Inc. (hereinafter referred to as the “Company,” “we,” “us,” or “our”) within the meaning of the Private Securities Litigation Reform Act of 1995 (the “PSLRA”). All such written or oral statements made in this press release, other than statements of historical fact, are forward-looking statements and are intended to be covered by the safe harbor for forward-looking statements provided by the PSLRA. Without limiting the foregoing, we may, in some cases, use terms such as “predicts,” “believes,” “potential,” “continue,” “estimates,” “anticipates,” “expects,” “plans,” “intends,” “forecast,” “guidance,” “outlook,” “may,” “could,” “might,” “will,” “should” or other words that convey uncertainty of future events or outcomes and are intended to identify forward-looking statements. Forward-looking statements are based on assumptions and assessments made in light of management’s experience and perception of historical trends, current conditions, expected future developments and other factors believed to be appropriate. Forward-looking statements in this press release are made as of the date of this press release, and we undertake no duty to update or revise any such statements, whether as a result of new information, future events or otherwise. Forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and other factors, many of which are outside of our control, that may cause actual results, levels of activity, performance, achievements and developments to be materially different from those expressed in or implied by these forward-looking statements. Important factors that could cause actual results, developments and business decisions to differ materially from forward-looking statements are described in the sections titled \"Risk Factors\" in our filings with the Securities and Exchange Commission, including our most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, and include, but are not limited to, the following substantial known and unknown risks and uncertainties inherent in our business: the effects of the COVID-19 pandemic; risks related to the timing of and our ability to successfully develop, submit, obtain and maintain U.S. Food and Drug Administration (“FDA”) or other regulatory authority approval of, or other action with respect to, our product candidates, and our ability to successfully commercialize any product candidates for which we obtain FDA approval; whether clinical trial results from our pivotal studies and cohorts, and meetings with the FDA, may support registrational studies and subsequent approvals by the FDA; preliminary and interim clinical results, which may include efficacy and safety results, from ongoing clinical trials or cohorts may not be reflected in the final analyses of our ongoing clinical trials or subgroups within these trials or in other prior trials or cohorts; the risk that enrollment may need to be adjusted for our trials and cohorts within those trials based on FDA and other regulatory agency input; the changing landscape of care for cervical cancer patients may impact our clinical trials in this indication; the risk that we may be required to conduct additional clinical trials or modify ongoing or future clinical trials based on feedback from the FDA or other regulatory authorities; the risk that our interpretation of the results of our clinical trials or communications with the FDA may differ from the interpretation of such results or communications by the FDA (including from the prior pre-BLA meeting with the FDA); the risk that the FDA may not approve or may delay approval for our BLA submission for lifileucel in metastatic melanoma; the acceptance by the market of our product candidates and their potential reimbursement by payors, if approved; our ability or inability to manufacture our therapies using third party manufacturers or our own facility may adversely affect our potential commercial launch; the results of clinical trials with collaborators using different manufacturing processes may not be reflected in our sponsored trials; the risk that unanticipated expenses may decrease our estimated cash balances and forecasts and increase our estimated capital requirements; and other factors, including general economic conditions and regulatory developments, not within our control.</p> <p><strong>CONTACTS</strong><br/><strong>Iovance Biotherapeutics, Inc</strong>:<br/>Sara Pellegrino, IRC<br/>Senior Vice President, Investor Relations &amp; Corporate Communications<br/>650-260-7120 ext. 264<br/>Sara.Pellegrino@iovance.com</p> <p>Jen Saunders<br/>Director, Investor Relations &amp; Public Relations<br/>267-485-3119<br/>Jen.Saunders@iovance.com</p> <br/><img referrerpolicy=\"no-referrer-when-downgrade\" src=\"https://ml.globenewswire.com/media/MmM1YmZiZjYtNzNkYi00ZDgyLWE3ODgtZmYyMzUwOGVjOWJhLTEwMzA3Njk=/tiny/Iovance-Biotherapeutics-Inc.png\"/></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK1103":"海运","IE00B12V2V27.USD":"柏瑞亚洲小盘股A(除日本)","SG9999011746.SGD":"PINEBRIDGE INTERNATIONAL FUNDS - ACORNS OF ASIA BA (SGD) ACC","IOVA":"Iovance Biotherapeutics, Inc.","BK4231":"零售房地产信托","IE00BYQNZ168.SGD":"PINEBRIDGE ASIA EX JAPAN SMALL CAP EQUITY \"A5CP\" (SGD) ACC","BK4505":"高瓴资本持仓","BK4139":"生物科技","BK1541":"物流","TIL":"Instil Bio, Inc.","01308":"海丰国际","IE00BYTNYN87.SGD":"PINEBRIDGE ASIA EX JAPAN SMALL CAP EQUITY \"A5\" (SGD) ACC","SITC":"SITE Centers Corp.","BK4080":"零售业房地产投资信托"},"source_url":"https://www.globenewswire.com/news-release/2023/10/31/2770278/0/en/Iovance-Biotherapeutics-to-Present-Clinical-and-Pre-Clinical-Data-for-Tumor-Infiltrating-Lymphocyte-TIL-Therapies-at-Society-for-Tumor-Immunotherapy-of-Cancer-s-SITC-38th-Annual-Me.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2379329541","content_text":"SAN CARLOS, Calif., Oct.  31, 2023  (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer, today announced the publication of abstracts for poster presentations reporting clinical data and trial design for tumor infiltrating lymphocyte (TIL) therapies at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting in San Diego, CA, November 1-5, 2023. An abstract on the four-year analysis of pooled Cohorts 2 and 4 of the C-144-01 trial reports the longest follow-up data on lifileucel treatment outcomes in the largest population of patients with anti–PD-1–refractory advanced melanoma treated with TIL therapy. As of the data cutoff date of June 16, 2023, median C-144-01 trial follow-up was 48.1 months in heavily pretreated patients with advanced melanoma. One-time lifileucel TIL therapy demonstrated durable efficacy with a four-year OS rate of 22.2%. The longest response was ongoing at 59.9 months. Treatment-emergent adverse events were consistent with known safety profiles of lymphodepletion and IL-2, and their incidence decreased over time. The four-year analysis further supports the use of lifileucel as a potential treatment option in these patients that is differentiated from other immunotherapies. Iovance Posters at SITC Annual Meeting Long-term efficacy and safety of lifileucel tumor infiltrating lymphocyte (TIL) cell therapy in patients with advanced melanoma: A 4-year analysis of the C-144-01 study Poster: Saturday, Nov. 4, 2023, 9:00 a.m.–8:30 p.m. PT Tumor infiltrating lymphocytes (TIL) with inducible and membrane-bound IL-12 exhibit superior antitumor activity in vitro Poster: Friday, Nov. 3, 2023, 9:00 a.m.–7:00 p.m. PT Trial-in-Progress: TILVANCE-301, a phase 3 study of lifileucel tumor infiltrating lymphocyte (TIL) cell therapy combined with pembrolizumab (pembro) vs pembro alone in treatment-naïve unresectable or metastatic melanoma Poster: Saturday, Nov. 4, 2023, 9:00 a.m.–8:30 p.m. PT  About Iovance Biotherapeutics, Inc.Iovance Biotherapeutics aims to be the global leader in innovating, developing and delivering tumor infiltrating lymphocyte (TIL) therapies for patients with cancer. We are pioneering a transformational approach to cure cancer by harnessing the human immune system’s ability to recognize and destroy diverse cancer cells in each patient. Our lead late-stage TIL product candidate, lifileucel for metastatic melanoma, has the potential to become the first approved one-time cell therapy for a solid tumor cancer. The Iovance TIL platform has demonstrated promising clinical data across multiple solid tumors. We are committed to continuous innovation in cell therapy, including gene-edited cell therapy, that may extend and improve life for patients with cancer. For more information, please visit www.iovance.com. Forward-Looking StatementsCertain matters discussed in this press release are “forward-looking statements” of Iovance Biotherapeutics, Inc. (hereinafter referred to as the “Company,” “we,” “us,” or “our”) within the meaning of the Private Securities Litigation Reform Act of 1995 (the “PSLRA”). All such written or oral statements made in this press release, other than statements of historical fact, are forward-looking statements and are intended to be covered by the safe harbor for forward-looking statements provided by the PSLRA. Without limiting the foregoing, we may, in some cases, use terms such as “predicts,” “believes,” “potential,” “continue,” “estimates,” “anticipates,” “expects,” “plans,” “intends,” “forecast,” “guidance,” “outlook,” “may,” “could,” “might,” “will,” “should” or other words that convey uncertainty of future events or outcomes and are intended to identify forward-looking statements. Forward-looking statements are based on assumptions and assessments made in light of management’s experience and perception of historical trends, current conditions, expected future developments and other factors believed to be appropriate. Forward-looking statements in this press release are made as of the date of this press release, and we undertake no duty to update or revise any such statements, whether as a result of new information, future events or otherwise. Forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and other factors, many of which are outside of our control, that may cause actual results, levels of activity, performance, achievements and developments to be materially different from those expressed in or implied by these forward-looking statements. Important factors that could cause actual results, developments and business decisions to differ materially from forward-looking statements are described in the sections titled \"Risk Factors\" in our filings with the Securities and Exchange Commission, including our most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, and include, but are not limited to, the following substantial known and unknown risks and uncertainties inherent in our business: the effects of the COVID-19 pandemic; risks related to the timing of and our ability to successfully develop, submit, obtain and maintain U.S. Food and Drug Administration (“FDA”) or other regulatory authority approval of, or other action with respect to, our product candidates, and our ability to successfully commercialize any product candidates for which we obtain FDA approval; whether clinical trial results from our pivotal studies and cohorts, and meetings with the FDA, may support registrational studies and subsequent approvals by the FDA; preliminary and interim clinical results, which may include efficacy and safety results, from ongoing clinical trials or cohorts may not be reflected in the final analyses of our ongoing clinical trials or subgroups within these trials or in other prior trials or cohorts; the risk that enrollment may need to be adjusted for our trials and cohorts within those trials based on FDA and other regulatory agency input; the changing landscape of care for cervical cancer patients may impact our clinical trials in this indication; the risk that we may be required to conduct additional clinical trials or modify ongoing or future clinical trials based on feedback from the FDA or other regulatory authorities; the risk that our interpretation of the results of our clinical trials or communications with the FDA may differ from the interpretation of such results or communications by the FDA (including from the prior pre-BLA meeting with the FDA); the risk that the FDA may not approve or may delay approval for our BLA submission for lifileucel in metastatic melanoma; the acceptance by the market of our product candidates and their potential reimbursement by payors, if approved; our ability or inability to manufacture our therapies using third party manufacturers or our own facility may adversely affect our potential commercial launch; the results of clinical trials with collaborators using different manufacturing processes may not be reflected in our sponsored trials; the risk that unanticipated expenses may decrease our estimated cash balances and forecasts and increase our estimated capital requirements; and other factors, including general economic conditions and regulatory developments, not within our control. CONTACTSIovance Biotherapeutics, Inc:Sara Pellegrino, IRCSenior Vice President, Investor Relations & Corporate Communications650-260-7120 ext. 264Sara.Pellegrino@iovance.com Jen SaundersDirector, Investor Relations & Public Relations267-485-3119Jen.Saunders@iovance.com","news_type":1},"isVote":1,"tweetType":1,"viewCount":521,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":650121087,"gmtCreate":1678977509450,"gmtModify":1678977934684,"author":{"id":"3537417120281286","authorId":"3537417120281286","name":"小白土兔","avatar":"https://static.tigerbbs.com/ed03e24159cdfb1a1cc9e0eb75d70106","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"垃圾","listText":"垃圾","text":"垃圾","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/650121087","repostId":"2318298841","repostType":2,"isVote":1,"tweetType":1,"viewCount":418,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":650112850,"gmtCreate":1678962152670,"gmtModify":1678962155433,"author":{"id":"3537417120281286","authorId":"3537417120281286","name":"小白土兔","avatar":"https://static.tigerbbs.com/ed03e24159cdfb1a1cc9e0eb75d70106","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/LKCO\">$箩筐技术(LKCO)$&nbsp;</a>这个**公司去哪里骂他们","listText":"<a href=\"https://laohu8.com/S/LKCO\">$箩筐技术(LKCO)$&nbsp;</a>这个**公司去哪里骂他们","text":"$箩筐技术(LKCO)$ 这个**公司去哪里骂他们","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/650112850","isVote":1,"tweetType":1,"viewCount":1156,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":627744285,"gmtCreate":1678715787147,"gmtModify":1678716640782,"author":{"id":"3537417120281286","authorId":"3537417120281286","name":"小白土兔","avatar":"https://static.tigerbbs.com/ed03e24159cdfb1a1cc9e0eb75d70106","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/LKCO\">$箩筐技术(LKCO)$&nbsp;</a>都是谁在买这垃圾股，哎","listText":"<a href=\"https://laohu8.com/S/LKCO\">$箩筐技术(LKCO)$&nbsp;</a>都是谁在买这垃圾股，哎","text":"$箩筐技术(LKCO)$ 都是谁在买这垃圾股，哎","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/627744285","isVote":1,"tweetType":1,"viewCount":1141,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":624980644,"gmtCreate":1677004238688,"gmtModify":1677004239730,"author":{"id":"3537417120281286","authorId":"3537417120281286","name":"小白土兔","avatar":"https://static.tigerbbs.com/ed03e24159cdfb1a1cc9e0eb75d70106","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/LKCO\">$箩筐技术(LKCO)$&nbsp;</a>箩筐之前合股过吗","listText":"<a href=\"https://laohu8.com/S/LKCO\">$箩筐技术(LKCO)$&nbsp;</a>箩筐之前合股过吗","text":"$箩筐技术(LKCO)$ 箩筐之前合股过吗","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/624980644","isVote":1,"tweetType":1,"viewCount":1453,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":624914629,"gmtCreate":1676998826361,"gmtModify":1676998827462,"author":{"id":"3537417120281286","authorId":"3537417120281286","name":"小白土兔","avatar":"https://static.tigerbbs.com/ed03e24159cdfb1a1cc9e0eb75d70106","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/LKCO\">$箩筐技术(LKCO)$&nbsp;</a>要合股了？","listText":"<a href=\"https://laohu8.com/S/LKCO\">$箩筐技术(LKCO)$&nbsp;</a>要合股了？","text":"$箩筐技术(LKCO)$ 要合股了？","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/624914629","isVote":1,"tweetType":1,"viewCount":749,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":625871481,"gmtCreate":1676386588543,"gmtModify":1676387939460,"author":{"id":"3537417120281286","authorId":"3537417120281286","name":"小白土兔","avatar":"https://static.tigerbbs.com/ed03e24159cdfb1a1cc9e0eb75d70106","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/VNET\">$世纪互联(VNET)$&nbsp;</a>扶不起的阿斗，新任的董真是垃圾","listText":"<a href=\"https://laohu8.com/S/VNET\">$世纪互联(VNET)$&nbsp;</a>扶不起的阿斗，新任的董真是垃圾","text":"$世纪互联(VNET)$ 扶不起的阿斗，新任的董真是垃圾","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/625871481","isVote":1,"tweetType":1,"viewCount":1086,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":628798931,"gmtCreate":1673458310724,"gmtModify":1673458311723,"author":{"id":"3537417120281286","authorId":"3537417120281286","name":"小白土兔","avatar":"https://static.tigerbbs.com/ed03e24159cdfb1a1cc9e0eb75d70106","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/LKCO\">$箩筐技术(LKCO)$&nbsp;</a>是不是要退市了","listText":"<a href=\"https://laohu8.com/S/LKCO\">$箩筐技术(LKCO)$&nbsp;</a>是不是要退市了","text":"$箩筐技术(LKCO)$ 是不是要退市了","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":5,"repostSize":0,"link":"https://laohu8.com/post/628798931","isVote":1,"tweetType":1,"viewCount":3115,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3578018187567110","authorId":"3578018187567110","name":"股神C","avatar":"https://static.tigerbbs.com/80ebf3f534f92f132c46d0657e9b48c6","crmLevel":2,"crmLevelSwitch":0},"content":"这个退市的话怎么搞 钱还回得来吗","text":"这个退市的话怎么搞 钱还回得来吗","html":"这个退市的话怎么搞 钱还回得来吗"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":851571598,"gmtCreate":1634916789962,"gmtModify":1634916789962,"author":{"id":"3537417120281286","authorId":"3537417120281286","name":"小白土兔","avatar":"https://static.tigerbbs.com/ed03e24159cdfb1a1cc9e0eb75d70106","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BYND\">$Beyond Meat, Inc.(BYND)$</a>真是不争气","listText":"<a href=\"https://laohu8.com/S/BYND\">$Beyond Meat, Inc.(BYND)$</a>真是不争气","text":"$Beyond Meat, Inc.(BYND)$真是不争气","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/851571598","isVote":1,"tweetType":1,"viewCount":1334,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":368744422,"gmtCreate":1614355143466,"gmtModify":1703476903100,"author":{"id":"3537417120281286","authorId":"3537417120281286","name":"小白土兔","avatar":"https://static.tigerbbs.com/ed03e24159cdfb1a1cc9e0eb75d70106","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"涨在哪里？","listText":"涨在哪里？","text":"涨在哪里？","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/368744422","repostId":"2114630592","repostType":2,"repost":{"id":"2114630592","pubTimestamp":1614349920,"share":"https://www.laohu8.com/m/news/2114630592?lang=&edition=full","pubTime":"2021-02-26 22:32","market":"sh","language":"zh","title":"Beyond Meat涨10%，宣布与百胜餐饮、麦当劳建立合作关系","url":"https://stock-news.laohu8.com/highlight/detail?id=2114630592","media":"新浪财经","summary":"Beyond Meat（BYND.O）涨10%，宣布与百胜餐饮、麦当劳建立合作关系。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：郭明煜","content":"<html><body><div>\n<p>　　Beyond Meat（<span>BYND</span><span></span>.O）涨10%，宣布与百胜餐饮、<span><a href=\"https://laohu8.com/S/MCD\">麦当劳</a></span><span></span>建立合作关系。</p>\n<div>\n<div><img src=\"\"/></div>\n<div>海量资讯、精准解读，尽在<a href=\"https://laohu8.com/S/SINA\">新浪</a>财经APP</div>\n</div>\n<p>责任编辑：郭明煜 </p>\n</div></body></html>","source":"sina","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Beyond Meat涨10%，宣布与百胜餐饮、麦当劳建立合作关系</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBeyond Meat涨10%，宣布与百胜餐饮、麦当劳建立合作关系\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-02-26 22:32 北京时间&nbsp;&nbsp;&nbsp;<a href=https://finance.sina.com.cn/stock/usstock/c/2021-02-26/doc-ikftssap8963459.shtml><strong>新浪财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Beyond Meat（BYND.O）涨10%，宣布与百胜餐饮、麦当劳建立合作关系。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：郭明煜</p>\n\n<a href=\"https://finance.sina.com.cn/stock/usstock/c/2021-02-26/doc-ikftssap8963459.shtml\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/5dbd4ef4cf9c9c3df70d9ff23af4de11","relate_stocks":{"BYND":"Beyond Meat, Inc.","08496":"环球友饮智能","MCD":"麦当劳"},"source_url":"https://finance.sina.com.cn/stock/usstock/c/2021-02-26/doc-ikftssap8963459.shtml","is_english":false,"share_image_url":"https://static.laohu8.com/b0d1b7e8843deea78cc308b15114de44","article_id":"2114630592","content_text":"Beyond Meat（BYND.O）涨10%，宣布与百胜餐饮、麦当劳建立合作关系。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：郭明煜","news_type":1},"isVote":1,"tweetType":1,"viewCount":1219,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":368744284,"gmtCreate":1614355128548,"gmtModify":1703476902757,"author":{"id":"3537417120281286","authorId":"3537417120281286","name":"小白土兔","avatar":"https://static.tigerbbs.com/ed03e24159cdfb1a1cc9e0eb75d70106","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"哈？","listText":"哈？","text":"哈？","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/368744284","repostId":"2114630592","repostType":2,"isVote":1,"tweetType":1,"viewCount":884,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":396949903,"gmtCreate":1607012126402,"gmtModify":1703845998612,"author":{"id":"3537417120281286","authorId":"3537417120281286","name":"小白土兔","avatar":"https://static.tigerbbs.com/ed03e24159cdfb1a1cc9e0eb75d70106","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/LKCO\">$箩筐技术(LKCO)$</a>好想卖你…","listText":"<a href=\"https://laohu8.com/S/LKCO\">$箩筐技术(LKCO)$</a>好想卖你…","text":"$箩筐技术(LKCO)$好想卖你…","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/396949903","isVote":1,"tweetType":1,"viewCount":893,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":393597314,"gmtCreate":1606317635538,"gmtModify":1703842616947,"author":{"id":"3537417120281286","authorId":"3537417120281286","name":"小白土兔","avatar":"https://static.tigerbbs.com/ed03e24159cdfb1a1cc9e0eb75d70106","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/LKCO\">$箩筐技术(LKCO)$</a>有意思吗？一天回去","listText":"<a href=\"https://laohu8.com/S/LKCO\">$箩筐技术(LKCO)$</a>有意思吗？一天回去","text":"$箩筐技术(LKCO)$有意思吗？一天回去","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/393597314","isVote":1,"tweetType":1,"viewCount":720,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":650112850,"gmtCreate":1678962152670,"gmtModify":1678962155433,"author":{"id":"3537417120281286","authorId":"3537417120281286","name":"小白土兔","avatar":"https://static.tigerbbs.com/ed03e24159cdfb1a1cc9e0eb75d70106","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/LKCO\">$箩筐技术(LKCO)$&nbsp;</a>这个**公司去哪里骂他们","listText":"<a href=\"https://laohu8.com/S/LKCO\">$箩筐技术(LKCO)$&nbsp;</a>这个**公司去哪里骂他们","text":"$箩筐技术(LKCO)$ 这个**公司去哪里骂他们","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/650112850","isVote":1,"tweetType":1,"viewCount":1156,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":628798931,"gmtCreate":1673458310724,"gmtModify":1673458311723,"author":{"id":"3537417120281286","authorId":"3537417120281286","name":"小白土兔","avatar":"https://static.tigerbbs.com/ed03e24159cdfb1a1cc9e0eb75d70106","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/LKCO\">$箩筐技术(LKCO)$&nbsp;</a>是不是要退市了","listText":"<a href=\"https://laohu8.com/S/LKCO\">$箩筐技术(LKCO)$&nbsp;</a>是不是要退市了","text":"$箩筐技术(LKCO)$ 是不是要退市了","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":5,"repostSize":0,"link":"https://laohu8.com/post/628798931","isVote":1,"tweetType":1,"viewCount":3115,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3578018187567110","authorId":"3578018187567110","name":"股神C","avatar":"https://static.tigerbbs.com/80ebf3f534f92f132c46d0657e9b48c6","crmLevel":2,"crmLevelSwitch":0},"content":"这个退市的话怎么搞 钱还回得来吗","text":"这个退市的话怎么搞 钱还回得来吗","html":"这个退市的话怎么搞 钱还回得来吗"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":978272892,"gmtCreate":1599239243916,"gmtModify":1703818237694,"author":{"id":"3537417120281286","authorId":"3537417120281286","name":"小白土兔","avatar":"https://static.tigerbbs.com/ed03e24159cdfb1a1cc9e0eb75d70106","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/LKCO\">$箩筐技术(LKCO)$</a>不上1块反正我是不卖了","listText":"<a href=\"https://laohu8.com/S/LKCO\">$箩筐技术(LKCO)$</a>不上1块反正我是不卖了","text":"$箩筐技术(LKCO)$不上1块反正我是不卖了","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/978272892","isVote":1,"tweetType":1,"viewCount":1776,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3546451183620891","authorId":"3546451183620891","name":"williamw","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0},"content":"多少买入的？","text":"多少买入的？","html":"多少买入的？"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":625871481,"gmtCreate":1676386588543,"gmtModify":1676387939460,"author":{"id":"3537417120281286","authorId":"3537417120281286","name":"小白土兔","avatar":"https://static.tigerbbs.com/ed03e24159cdfb1a1cc9e0eb75d70106","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/VNET\">$世纪互联(VNET)$&nbsp;</a>扶不起的阿斗，新任的董真是垃圾","listText":"<a href=\"https://laohu8.com/S/VNET\">$世纪互联(VNET)$&nbsp;</a>扶不起的阿斗，新任的董真是垃圾","text":"$世纪互联(VNET)$ 扶不起的阿斗，新任的董真是垃圾","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/625871481","isVote":1,"tweetType":1,"viewCount":1086,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":302801145,"gmtCreate":1604586742587,"gmtModify":1703833936189,"author":{"id":"3537417120281286","authorId":"3537417120281286","name":"小白土兔","avatar":"https://static.tigerbbs.com/ed03e24159cdfb1a1cc9e0eb75d70106","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/LKCO\">$箩筐技术(LKCO)$</a>骂不动了","listText":"<a href=\"https://laohu8.com/S/LKCO\">$箩筐技术(LKCO)$</a>骂不动了","text":"$箩筐技术(LKCO)$骂不动了","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/302801145","isVote":1,"tweetType":1,"viewCount":1125,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":929679750,"gmtCreate":1585327840570,"gmtModify":1704357946207,"author":{"id":"3537417120281286","authorId":"3537417120281286","name":"小白土兔","avatar":"https://static.tigerbbs.com/ed03e24159cdfb1a1cc9e0eb75d70106","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/LKCO\">$箩筐技术(LKCO)$</a>好奇是谁在买？","listText":"<a href=\"https://laohu8.com/S/LKCO\">$箩筐技术(LKCO)$</a>好奇是谁在买？","text":"$箩筐技术(LKCO)$好奇是谁在买？","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/929679750","isVote":1,"tweetType":1,"viewCount":1115,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":624980644,"gmtCreate":1677004238688,"gmtModify":1677004239730,"author":{"id":"3537417120281286","authorId":"3537417120281286","name":"小白土兔","avatar":"https://static.tigerbbs.com/ed03e24159cdfb1a1cc9e0eb75d70106","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/LKCO\">$箩筐技术(LKCO)$&nbsp;</a>箩筐之前合股过吗","listText":"<a href=\"https://laohu8.com/S/LKCO\">$箩筐技术(LKCO)$&nbsp;</a>箩筐之前合股过吗","text":"$箩筐技术(LKCO)$ 箩筐之前合股过吗","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/624980644","isVote":1,"tweetType":1,"viewCount":1453,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":390379530,"gmtCreate":1605716160020,"gmtModify":1703839240550,"author":{"id":"3537417120281286","authorId":"3537417120281286","name":"小白土兔","avatar":"https://static.tigerbbs.com/ed03e24159cdfb1a1cc9e0eb75d70106","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/LKCO\">$箩筐技术(LKCO)$</a>这个公司到底靠啥盈利都搞不懂","listText":"<a href=\"https://laohu8.com/S/LKCO\">$箩筐技术(LKCO)$</a>这个公司到底靠啥盈利都搞不懂","text":"$箩筐技术(LKCO)$这个公司到底靠啥盈利都搞不懂","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/390379530","isVote":1,"tweetType":1,"viewCount":1741,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":924890979,"gmtCreate":1588264516491,"gmtModify":1704367215190,"author":{"id":"3537417120281286","authorId":"3537417120281286","name":"小白土兔","avatar":"https://static.tigerbbs.com/ed03e24159cdfb1a1cc9e0eb75d70106","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/NIO\">$蔚来(NIO)$</a>辣鸡","listText":"<a href=\"https://laohu8.com/S/NIO\">$蔚来(NIO)$</a>辣鸡","text":"$蔚来(NIO)$辣鸡","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/924890979","isVote":1,"tweetType":1,"viewCount":764,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":923990394,"gmtCreate":1585669205518,"gmtModify":1704358635690,"author":{"id":"3537417120281286","authorId":"3537417120281286","name":"小白土兔","avatar":"https://static.tigerbbs.com/ed03e24159cdfb1a1cc9e0eb75d70106","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/LKCO\">$箩筐技术(LKCO)$</a>红烧辣子鸡","listText":"<a href=\"https://laohu8.com/S/LKCO\">$箩筐技术(LKCO)$</a>红烧辣子鸡","text":"$箩筐技术(LKCO)$红烧辣子鸡","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/923990394","isVote":1,"tweetType":1,"viewCount":464,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":304430697,"gmtCreate":1605278936619,"gmtModify":1703837211847,"author":{"id":"3537417120281286","authorId":"3537417120281286","name":"小白土兔","avatar":"https://static.tigerbbs.com/ed03e24159cdfb1a1cc9e0eb75d70106","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/LKCO\">$箩筐技术(LKCO)$</a>吐了，下周三如果还涨就卖，太恶心了","listText":"<a href=\"https://laohu8.com/S/LKCO\">$箩筐技术(LKCO)$</a>吐了，下周三如果还涨就卖，太恶心了","text":"$箩筐技术(LKCO)$吐了，下周三如果还涨就卖，太恶心了","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/304430697","isVote":1,"tweetType":1,"viewCount":622,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":951112885,"gmtCreate":1590677741847,"gmtModify":1704193400749,"author":{"id":"3537417120281286","authorId":"3537417120281286","name":"小白土兔","avatar":"https://static.tigerbbs.com/ed03e24159cdfb1a1cc9e0eb75d70106","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/NIO\">$蔚来(NIO)$</a>都说财报好，怎么还跌？","listText":"<a href=\"https://laohu8.com/S/NIO\">$蔚来(NIO)$</a>都说财报好，怎么还跌？","text":"$蔚来(NIO)$都说财报好，怎么还跌？","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/951112885","isVote":1,"tweetType":1,"viewCount":798,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":298692875362304,"gmtCreate":1713931923490,"gmtModify":1713931925456,"author":{"id":"3537417120281286","authorId":"3537417120281286","name":"小白土兔","avatar":"https://static.tigerbbs.com/ed03e24159cdfb1a1cc9e0eb75d70106","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"什么鬼都能上市圈钱了","listText":"什么鬼都能上市圈钱了","text":"什么鬼都能上市圈钱了","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/298692875362304","repostId":"2429213117","repostType":2,"repost":{"id":"2429213117","pubTimestamp":1713889847,"share":"https://www.laohu8.com/m/news/2429213117?lang=&edition=full","pubTime":"2024-04-24 00:30","market":"hk","language":"zh","title":"“新茶饮第二股”茶百道登陆港交所主板 多家茶饮品牌加速推进上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2429213117","media":"证券日报","summary":"4月23日，新茶饮品牌“茶百道”母公司四川百茶百道实业股份有限公司（以下简称“茶百道”）正式于港交所主板挂牌。本次茶百道发行1.48亿股H股，发行价为每股17.50港元，募资总额高达25.9亿港元。招股书显示，本次募集资金主要用于提高整体运营能力及强化供应链、发展数字化能力以及委聘和培训专业人才等。","content":"<html><body><div>\n<p><img border=\"0\" height=\"276\" src=\"https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=116.02555&amp;imageType=k&amp;token=28dfeb41d35cc81d84b4664d7c23c49f&amp;at=1\" width=\"578\"/></p><p>　　4月23日，新茶饮品牌“<span><a href=\"https://laohu8.com/S/02555\">茶百道</a></span>”母公司四川百<span href=\"http://quote.eastmoney.com/unify/r/116.02555\" target=\"_blank\" web=\"1\">茶百道</span>实业股份有限公司（以下简称“<span href=\"http://quote.eastmoney.com/unify/r/116.02555\" target=\"_blank\" web=\"1\">茶百道</span>”）正式于港交所主板挂牌。本次茶百道发行1.48亿股H股，发行价为每股17.50港元，募资总额高达25.9亿港元。</p> <p>　　招股书显示，本次募集资金主要用于提高整体运营能力及强化供应链、发展数字化能力以及委聘和培训专业人才等。</p> <p>　　中国企业资本联盟副理事长柏文喜对《<span>证券</span><span></span>日报》记者表示：“茶百道的上市不仅凸显了新茶饮市场的发展空间，还体现了资本市场对新茶饮行业的青睐。”</p> <p>　　<strong>加速布局下沉市场</strong></p> <p>　　茶百道招股书显示，公司成立于2008年，首家门店开在成都。2021年至2023年，茶百道收入分别为36.44亿元、42.32亿元、57.04亿元，毛利分别为13.01亿元、14.56亿元、19.64亿元，同期毛利率分别为35.7%、34.4%及34.4%。</p> <p>　　截至2024年4月5日，茶百道门店数已经达到8016家，实现所有省份及各线级城市的全覆盖。根据弗若斯特沙利文的报告，2023年，中国现制茶饮店市场规模为2473亿元。按零售额计，前五大参与者合共占据约40.2%的市场份额，茶百道以约6.8%的市场份额位居第三。</p> <p>　　茶百道门店主要分布在新一线城市和二线城市，同时，三四线城市门店数量的占比也在提高。</p> <p>　　招股书显示，到2023年底，茶百道门店在一线、新一线、二线、三线、四线及以下城市的数量占比分别为10.6%、26.9%、20.9%、19.4%及22.2%。茶百道称，低线级城市存在较大的市场空间，因此计划进一步在二线及以下的城市进行门店加密，抢占下沉市场。</p> <p>　　<span><a href=\"https://laohu8.com/S/00506\">中国食品</a></span>产业研究院高级研究员朱丹蓬对《<span href=\"http://quote.eastmoney.com/unify/r/90.BK0473\" target=\"_blank\" web=\"1\">证券</span>日报》记者表示，在下沉市场的竞争中，茶百道对县镇消费者的吸引力是非常大的，很可能会对区域性品牌形成降维打击。</p> <p>　　根据弗若斯特沙利文的报告，2024年至2028年，二线城市、三线城市、四线及以下城市的现制茶饮店市场预计将分别以15.0%、18.0%、15.0%的年复合增长率进一步增长。种种数据表明，对于新茶饮企业而言，三线城市、四线及以下城市的市场规模和增长速度都极具吸引力。</p> <p>　　<strong>多家茶饮品牌拟IPO</strong></p> <p>　　据了解，除茶百道外，今年年初，古茗控股有限公司向港交所递交招股书，保荐人为<span><a href=\"https://laohu8.com/S/GS\">高盛</a></span><span></span>、瑞银。同一天，蜜雪冰城股份有限公司也向港交所递交招股书。今年3月份，沪上阿姨（上海）实业股份有限公司递表港交所。目前，上述3家茶饮企业仍处在审核阶段。</p> <p>　　晶捷互动创始人陈晶晶对《<span href=\"http://quote.eastmoney.com/unify/r/90.BK0473\" target=\"_blank\" web=\"1\">证券</span>日报》记者表示，在高端茶饮市场竞争格局基本已经固定的情况下，众多品牌提交上市申请，说明这些品牌急需借助资本市场的力量做大规模、做优产品、做实口碑，实现快速发展以应对可能到来的市场洗牌。</p> <p>　　中央财经大学副教授刘春生对《证券日报》记者表示，企业扎堆赴港上市说明尽管新茶饮备受资本关注，扩张速度快，但由于前期投入巨大，其盈利能力尚需市场检验，行业正处于快速发展和竞争激烈的阶段。对于企业来说，赴港上市可以拓宽融资渠道，提升品牌知名度和市场竞争力。</p> <p>　　除了已经在排队上市的企业外，也有新茶饮品牌传出上市计划。</p> <p>　　现制茶饮市场是中国饮品市场的重要组成部分，也是近年来最具活力和增长潜力的细分领域之一。据弗若斯特沙利文的数据，中国现制茶饮的规模从2018年的805亿元增长至2023年的2473亿元，预计到2028年将达到5385亿元，年均复合增长率为16.8%。</p><p>（文章来源：证券日报）</p> </div></body></html>","source":"stock_eastmoney","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>“新茶饮第二股”茶百道登陆港交所主板 多家茶饮品牌加速推进上市</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n“新茶饮第二股”茶百道登陆港交所主板 多家茶饮品牌加速推进上市\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-04-24 00:30 北京时间&nbsp;&nbsp;&nbsp;<a href=http://finance.eastmoney.com/a/202404243056352715.html><strong>证券日报</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>4月23日，新茶饮品牌“茶百道”母公司四川百茶百道实业股份有限公司（以下简称“茶百道”）正式于港交所主板挂牌。本次茶百道发行1.48亿股H股，发行价为每股17.50港元，募资总额高达25.9亿港元。 　　招股书显示，本次募集资金主要用于提高整体运营能力及强化供应链、发展数字化能力以及委聘和培训专业人才等。 　　中国企业资本联盟副理事长柏文喜对《证券日报》记者表示：“茶百道的上市不仅凸显了新茶饮市场...</p>\n\n<a href=\"http://finance.eastmoney.com/a/202404243056352715.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"02555":"茶百道"},"source_url":"http://finance.eastmoney.com/a/202404243056352715.html","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2429213117","content_text":"4月23日，新茶饮品牌“茶百道”母公司四川百茶百道实业股份有限公司（以下简称“茶百道”）正式于港交所主板挂牌。本次茶百道发行1.48亿股H股，发行价为每股17.50港元，募资总额高达25.9亿港元。 　　招股书显示，本次募集资金主要用于提高整体运营能力及强化供应链、发展数字化能力以及委聘和培训专业人才等。 　　中国企业资本联盟副理事长柏文喜对《证券日报》记者表示：“茶百道的上市不仅凸显了新茶饮市场的发展空间，还体现了资本市场对新茶饮行业的青睐。” 　　加速布局下沉市场 　　茶百道招股书显示，公司成立于2008年，首家门店开在成都。2021年至2023年，茶百道收入分别为36.44亿元、42.32亿元、57.04亿元，毛利分别为13.01亿元、14.56亿元、19.64亿元，同期毛利率分别为35.7%、34.4%及34.4%。 　　截至2024年4月5日，茶百道门店数已经达到8016家，实现所有省份及各线级城市的全覆盖。根据弗若斯特沙利文的报告，2023年，中国现制茶饮店市场规模为2473亿元。按零售额计，前五大参与者合共占据约40.2%的市场份额，茶百道以约6.8%的市场份额位居第三。 　　茶百道门店主要分布在新一线城市和二线城市，同时，三四线城市门店数量的占比也在提高。 　　招股书显示，到2023年底，茶百道门店在一线、新一线、二线、三线、四线及以下城市的数量占比分别为10.6%、26.9%、20.9%、19.4%及22.2%。茶百道称，低线级城市存在较大的市场空间，因此计划进一步在二线及以下的城市进行门店加密，抢占下沉市场。 　　中国食品产业研究院高级研究员朱丹蓬对《证券日报》记者表示，在下沉市场的竞争中，茶百道对县镇消费者的吸引力是非常大的，很可能会对区域性品牌形成降维打击。 　　根据弗若斯特沙利文的报告，2024年至2028年，二线城市、三线城市、四线及以下城市的现制茶饮店市场预计将分别以15.0%、18.0%、15.0%的年复合增长率进一步增长。种种数据表明，对于新茶饮企业而言，三线城市、四线及以下城市的市场规模和增长速度都极具吸引力。 　　多家茶饮品牌拟IPO 　　据了解，除茶百道外，今年年初，古茗控股有限公司向港交所递交招股书，保荐人为高盛、瑞银。同一天，蜜雪冰城股份有限公司也向港交所递交招股书。今年3月份，沪上阿姨（上海）实业股份有限公司递表港交所。目前，上述3家茶饮企业仍处在审核阶段。 　　晶捷互动创始人陈晶晶对《证券日报》记者表示，在高端茶饮市场竞争格局基本已经固定的情况下，众多品牌提交上市申请，说明这些品牌急需借助资本市场的力量做大规模、做优产品、做实口碑，实现快速发展以应对可能到来的市场洗牌。 　　中央财经大学副教授刘春生对《证券日报》记者表示，企业扎堆赴港上市说明尽管新茶饮备受资本关注，扩张速度快，但由于前期投入巨大，其盈利能力尚需市场检验，行业正处于快速发展和竞争激烈的阶段。对于企业来说，赴港上市可以拓宽融资渠道，提升品牌知名度和市场竞争力。 　　除了已经在排队上市的企业外，也有新茶饮品牌传出上市计划。 　　现制茶饮市场是中国饮品市场的重要组成部分，也是近年来最具活力和增长潜力的细分领域之一。据弗若斯特沙利文的数据，中国现制茶饮的规模从2018年的805亿元增长至2023年的2473亿元，预计到2028年将达到5385亿元，年均复合增长率为16.8%。（文章来源：证券日报）","news_type":1},"isVote":1,"tweetType":1,"viewCount":24,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":285745287102776,"gmtCreate":1710780485229,"gmtModify":1710780487194,"author":{"id":"3537417120281286","authorId":"3537417120281286","name":"小白土兔","avatar":"https://static.tigerbbs.com/ed03e24159cdfb1a1cc9e0eb75d70106","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"亿航开盘即巅峰，现在竟然能变成跌的，真的拉胯啊","listText":"亿航开盘即巅峰，现在竟然能变成跌的，真的拉胯啊","text":"亿航开盘即巅峰，现在竟然能变成跌的，真的拉胯啊","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/285745287102776","repostId":"1190618566","repostType":2,"repost":{"id":"1190618566","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1710762444,"share":"https://www.laohu8.com/m/news/1190618566?lang=&edition=full","pubTime":"2024-03-18 19:47","market":"us","language":"zh","title":"盘前 | 谷歌涨超5%！超微电脑、英伟达涨逾3%；“空中的士”淘宝开售，亿航智能涨超13%","url":"https://stock-news.laohu8.com/highlight/detail?id=1190618566","media":"老虎资讯综合","summary":"谷歌盘前涨超5%！首款国产“空中的士”淘宝开售！亿航智能盘前涨超13%今日全球首个获得适航认证的国产自研“空中的士”亿航EH216-S在淘宝上架，标价239万元。据悉，该“空中的士”为全智能无人驾驶航空器，可搭载两人，能够全智能低空飞行和垂直起降，完全不需要跑道。受此消息影响，亿航智能盘前涨超13%。$超微电脑$盘前涨近3%，今日起正式纳入标普指数。$小牛电动$盘前跌超3%，Q4营收同比下降21.8%。","content":"<html><head></head><body><p><strong>摘要：</strong></p><ul style=\"\"><li><p><a href=\"https://laohu8.com/S/NVDA\">英伟达</a>GTC大会重磅来袭，盘前股价涨近3%</p></li><li><p><a href=\"https://laohu8.com/S/GOOG\">谷歌</a>盘前涨超5%！报道：<a href=\"https://laohu8.com/S/AAPL\">苹果</a>正在谈判将谷歌的Gemini人工<a href=\"https://laohu8.com/S/5RE.SI\">智能</a>引擎植入iPhone</p></li><li><p><a href=\"https://laohu8.com/S/QCOM\">高通</a>推出第三代骁龙8s移动平台，支持终端侧生成式AI功能</p></li><li><p><a href=\"https://laohu8.com/S/SMCI\">超微电脑</a>今日起正式纳入标普指数</p></li><li><p><a href=\"https://laohu8.com/S/TSLA\">特斯拉</a>盘前涨超3%，宣布Model Y在欧洲多国提价</p></li><li><p>首款国产“空中的士”淘宝开售！<a href=\"https://laohu8.com/S/EH\">亿航智能</a>盘前涨超13%</p></li><li><p><a href=\"https://laohu8.com/S/PFE\">辉瑞</a>计划出售约6.3亿股<a href=\"https://laohu8.com/S/HLN\">Haleon</a>股票</p></li></ul><p>3月18日，美股三大股指期货上涨，截止发稿，道指期货涨0.12%，纳指期货涨1.10%，标普500指数期货涨0.69%。</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/032cdd1e5d59e72bcaaf50c56b8cd4e3\" title=\"\" tg-width=\"428\" tg-height=\"191\"/></p><h3 id=\"id_1214499721\">盘前要闻</h3><p><strong>英伟达GTC大会重磅来袭，盘前股价涨近3%</strong></p><p>3月18日-21日，英伟达AI大会GTC 2024将在美国圣何塞会议中心举行。今日（北京时间3月19日凌晨4点），英伟达CEO黄仁勋将进行主题为“面向开发者的1#AI峰会”演讲。据英伟达介绍，黄仁勋届时将发布加速计算、生成式AI以及<a href=\"https://laohu8.com/S/300024\">机器人</a>领域的最新突破性成果。</p><p>市场普遍认为，此次大会焦点有4个：1.下一代Blackwell GPU架构，2.新款B100芯片，3.人形机器人，4.AI+医药。华尔街预计，本届GTC将帮助英伟达股票结束近期的震荡走势，并继续保持今年迄今超过80%的强劲增长势头。</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/69f1ce094b052f65a9f51bf3c9462ad2\" title=\"\" tg-width=\"302\" tg-height=\"144\"/></p><p><strong>谷歌盘前涨超5%！报道：苹果正在谈判将谷歌的Gemini人工智能引擎植入iPhone</strong></p><p>据媒体援引知情人士消息，苹果与谷歌两家公司正在积极谈判，希望让苹果获得Gemini的授权，为今年iPhone软件的一些新功能提供支持。此外，苹果最近还与OpenAI进行讨论并考虑使用其模型。据报道，苹果希望获得相关许可，使用Gemini模型为iOS 18加入全新生成式AI功能。此前报道指出，分析师Mark Gurman透露，即将在今年6月发布的iOS 18，将会是苹果iOS史上最大更新，而其更新的关键就是围绕“AI”展开。</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/73b10c8ad885885b2ef5f3dba1ca9b36\" title=\"\" tg-width=\"299\" tg-height=\"152\"/></p><p><strong>首款国产“空中的士”淘宝开售！亿航智能盘前涨超13%</strong></p><p>今日全球首个获得适航认证的国产自研“空中的士”亿航EH216-S在淘宝上架，标价239万元。据悉，该“空中的士”为全智能无人驾驶航空器，可搭载两人，能够全智能低空飞行和垂直起降，完全不需要跑道。行业人士分析，作为新质生产力的代表，低空经济正走向落地普惠的阶段，“空中的士”的上架迈出了向低空自由飞行的坚实一步。受此消息影响，亿航智能盘前涨超13%。</p><p><strong>高通推出第三代骁龙8s移动平台，支持终端侧生成式AI功能</strong></p><p>北京时间3月18日下午，高通宣布推出全新的第三代骁龙8s移动平台，该平台将具备终端侧生成式AI功能以及始终感知的ISP。高通方面表示，骁龙8s平台支持绝大部分主流AI模型，包括百川智能的Baichuan-7B、谷歌旗下的Gemini Nano、Meta旗下的Llama 2和智谱ChatGLM等。受此消息影响，高通盘前涨超1%。</p><p><strong>辉瑞计划出售约6.3亿股Haleon股票</strong></p><p>英国消费保健巨头Haleon周一表示，辉瑞将出售其在该公司的约6.3亿股股份，将其持股减少到24%左右。辉瑞目前持有Haleon的32%股份，该公司去年5月宣布，计划在几个月内以“缓慢而有条理”的方式减持股权。Haleon在一份声明中表示，辉瑞出售其股份的价格预计将在3月19日左右公布，届时将完成簿记程序。</p><p><strong><a href=\"https://laohu8.com/S/F\">福特汽车</a>据称正开发一款售价2.5万美元的紧凑型电动车</strong></p><p>消息人士：福特汽车据称正在开发一款售价为2.5万美元的紧凑型电动车，预计将于2026年底首次亮相。福特汽车新的电动车平台将采用更便宜的锂铁磷酸(LFP)电池。福特汽车紧凑型车型是三款新的低成本电动车之一。</p><h3 id=\"id_3415585353\">盘前行情</h3><p>特斯拉(TSLA)$盘前涨超3%，宣布Model Y在欧洲多国提价2000欧元。当地时间上周六，<a href=\"https://laohu8.com/S/TSLA\">特斯拉</a>在X平台的官方账号宣布，将于3月22日在多个欧洲国家提高其Model Y电动汽车的价格，涨幅约为2000欧元(约2177美元)，或当地货币等值。此前一天，特斯拉宣布从4月1日起，将在美国销售的Model Y价格上调1000美元。这将是特斯拉Model Y一个月内第二次提价。3月1日，特斯拉已将Model Y后轮驱动版和远程版的价格分别提高了1000美元，至43990美元和48990美元。</p><p><a href=\"https://laohu8.com/S/SMCI\">超微电脑</a>盘前涨近3%，今日起正式纳入标普指数。</p><p>部分中概股上涨，<a href=\"https://laohu8.com/S/XPEV\">小鹏汽车</a>涨超6%，<a href=\"https://laohu8.com/S/NIO\">蔚来</a>涨超4%，<a href=\"https://laohu8.com/S/BILI\">哔哩哔哩</a>、<a href=\"https://laohu8.com/S/PDD\">拼多多</a>涨超2%。</p><p><a href=\"https://laohu8.com/S/LI\">理想汽车</a>盘前跌超5%，“MEGA”据报订单逊预期，管理层考虑下调销售目标。</p><p><a href=\"https://laohu8.com/S/HLN\">Haleon</a>盘前跌超1%，<a href=\"https://laohu8.com/S/PFE\">辉瑞</a>计划出售约6.3亿股<a href=\"https://laohu8.com/S/HLN\">Haleon</a>股票。</p><p><a href=\"https://laohu8.com/S/NIU\">小牛电动</a>盘前跌超3%，Q4营收同比下降21.8%。</p><p><a href=\"https://laohu8.com/S/LOGI\">罗技</a>股价盘前跌近6%，公司首席财务官辞职。</p><p>Shift4盘前跌超8%，公司CEO称潜在收购出价未充分反映价值。</p><h3 id=\"id_1154522510\">欧洲市场</h3><p>欧洲主要指数涨多跌少，德国DAX30涨0.36%，法国CAC40涨0.18%。</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/f2dbb9a82bf17cc786ea9c6de70cb5a9\" title=\"\" tg-width=\"1431\" tg-height=\"565\"/></p><h3 id=\"id_2405271039\">原油</h3><p>国际油价上涨，美油报81.09美元/桶，日内涨幅0.63%；布油现报85.80美元/桶，日内涨幅0.54%。</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/196fba7701318c85bdefd6a1b3424937\" title=\"\" tg-width=\"1415\" tg-height=\"90\"/></p><h3 id=\"id_89612189\">黄金</h3><p>现货黄金日内涨0.12%，报2,163.85美元/盎司。</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/50fe7834a761630db4d0282ac207cf48\" title=\"\" tg-width=\"560\" tg-height=\"240\"/></p><p></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>盘前 | 谷歌涨超5%！超微电脑、英伟达涨逾3%；“空中的士”淘宝开售，亿航智能涨超13%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n盘前 | 谷歌涨超5%！超微电脑、英伟达涨逾3%；“空中的士”淘宝开售，亿航智能涨超13%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2024-03-18 19:47</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p><strong>摘要：</strong></p><ul style=\"\"><li><p><a href=\"https://laohu8.com/S/NVDA\">英伟达</a>GTC大会重磅来袭，盘前股价涨近3%</p></li><li><p><a href=\"https://laohu8.com/S/GOOG\">谷歌</a>盘前涨超5%！报道：<a href=\"https://laohu8.com/S/AAPL\">苹果</a>正在谈判将谷歌的Gemini人工<a href=\"https://laohu8.com/S/5RE.SI\">智能</a>引擎植入iPhone</p></li><li><p><a href=\"https://laohu8.com/S/QCOM\">高通</a>推出第三代骁龙8s移动平台，支持终端侧生成式AI功能</p></li><li><p><a href=\"https://laohu8.com/S/SMCI\">超微电脑</a>今日起正式纳入标普指数</p></li><li><p><a href=\"https://laohu8.com/S/TSLA\">特斯拉</a>盘前涨超3%，宣布Model Y在欧洲多国提价</p></li><li><p>首款国产“空中的士”淘宝开售！<a href=\"https://laohu8.com/S/EH\">亿航智能</a>盘前涨超13%</p></li><li><p><a href=\"https://laohu8.com/S/PFE\">辉瑞</a>计划出售约6.3亿股<a href=\"https://laohu8.com/S/HLN\">Haleon</a>股票</p></li></ul><p>3月18日，美股三大股指期货上涨，截止发稿，道指期货涨0.12%，纳指期货涨1.10%，标普500指数期货涨0.69%。</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/032cdd1e5d59e72bcaaf50c56b8cd4e3\" title=\"\" tg-width=\"428\" tg-height=\"191\"/></p><h3 id=\"id_1214499721\">盘前要闻</h3><p><strong>英伟达GTC大会重磅来袭，盘前股价涨近3%</strong></p><p>3月18日-21日，英伟达AI大会GTC 2024将在美国圣何塞会议中心举行。今日（北京时间3月19日凌晨4点），英伟达CEO黄仁勋将进行主题为“面向开发者的1#AI峰会”演讲。据英伟达介绍，黄仁勋届时将发布加速计算、生成式AI以及<a href=\"https://laohu8.com/S/300024\">机器人</a>领域的最新突破性成果。</p><p>市场普遍认为，此次大会焦点有4个：1.下一代Blackwell GPU架构，2.新款B100芯片，3.人形机器人，4.AI+医药。华尔街预计，本届GTC将帮助英伟达股票结束近期的震荡走势，并继续保持今年迄今超过80%的强劲增长势头。</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/69f1ce094b052f65a9f51bf3c9462ad2\" title=\"\" tg-width=\"302\" tg-height=\"144\"/></p><p><strong>谷歌盘前涨超5%！报道：苹果正在谈判将谷歌的Gemini人工智能引擎植入iPhone</strong></p><p>据媒体援引知情人士消息，苹果与谷歌两家公司正在积极谈判，希望让苹果获得Gemini的授权，为今年iPhone软件的一些新功能提供支持。此外，苹果最近还与OpenAI进行讨论并考虑使用其模型。据报道，苹果希望获得相关许可，使用Gemini模型为iOS 18加入全新生成式AI功能。此前报道指出，分析师Mark Gurman透露，即将在今年6月发布的iOS 18，将会是苹果iOS史上最大更新，而其更新的关键就是围绕“AI”展开。</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/73b10c8ad885885b2ef5f3dba1ca9b36\" title=\"\" tg-width=\"299\" tg-height=\"152\"/></p><p><strong>首款国产“空中的士”淘宝开售！亿航智能盘前涨超13%</strong></p><p>今日全球首个获得适航认证的国产自研“空中的士”亿航EH216-S在淘宝上架，标价239万元。据悉，该“空中的士”为全智能无人驾驶航空器，可搭载两人，能够全智能低空飞行和垂直起降，完全不需要跑道。行业人士分析，作为新质生产力的代表，低空经济正走向落地普惠的阶段，“空中的士”的上架迈出了向低空自由飞行的坚实一步。受此消息影响，亿航智能盘前涨超13%。</p><p><strong>高通推出第三代骁龙8s移动平台，支持终端侧生成式AI功能</strong></p><p>北京时间3月18日下午，高通宣布推出全新的第三代骁龙8s移动平台，该平台将具备终端侧生成式AI功能以及始终感知的ISP。高通方面表示，骁龙8s平台支持绝大部分主流AI模型，包括百川智能的Baichuan-7B、谷歌旗下的Gemini Nano、Meta旗下的Llama 2和智谱ChatGLM等。受此消息影响，高通盘前涨超1%。</p><p><strong>辉瑞计划出售约6.3亿股Haleon股票</strong></p><p>英国消费保健巨头Haleon周一表示，辉瑞将出售其在该公司的约6.3亿股股份，将其持股减少到24%左右。辉瑞目前持有Haleon的32%股份，该公司去年5月宣布，计划在几个月内以“缓慢而有条理”的方式减持股权。Haleon在一份声明中表示，辉瑞出售其股份的价格预计将在3月19日左右公布，届时将完成簿记程序。</p><p><strong><a href=\"https://laohu8.com/S/F\">福特汽车</a>据称正开发一款售价2.5万美元的紧凑型电动车</strong></p><p>消息人士：福特汽车据称正在开发一款售价为2.5万美元的紧凑型电动车，预计将于2026年底首次亮相。福特汽车新的电动车平台将采用更便宜的锂铁磷酸(LFP)电池。福特汽车紧凑型车型是三款新的低成本电动车之一。</p><h3 id=\"id_3415585353\">盘前行情</h3><p>特斯拉(TSLA)$盘前涨超3%，宣布Model Y在欧洲多国提价2000欧元。当地时间上周六，<a href=\"https://laohu8.com/S/TSLA\">特斯拉</a>在X平台的官方账号宣布，将于3月22日在多个欧洲国家提高其Model Y电动汽车的价格，涨幅约为2000欧元(约2177美元)，或当地货币等值。此前一天，特斯拉宣布从4月1日起，将在美国销售的Model Y价格上调1000美元。这将是特斯拉Model Y一个月内第二次提价。3月1日，特斯拉已将Model Y后轮驱动版和远程版的价格分别提高了1000美元，至43990美元和48990美元。</p><p><a href=\"https://laohu8.com/S/SMCI\">超微电脑</a>盘前涨近3%，今日起正式纳入标普指数。</p><p>部分中概股上涨，<a href=\"https://laohu8.com/S/XPEV\">小鹏汽车</a>涨超6%，<a href=\"https://laohu8.com/S/NIO\">蔚来</a>涨超4%，<a href=\"https://laohu8.com/S/BILI\">哔哩哔哩</a>、<a href=\"https://laohu8.com/S/PDD\">拼多多</a>涨超2%。</p><p><a href=\"https://laohu8.com/S/LI\">理想汽车</a>盘前跌超5%，“MEGA”据报订单逊预期，管理层考虑下调销售目标。</p><p><a href=\"https://laohu8.com/S/HLN\">Haleon</a>盘前跌超1%，<a href=\"https://laohu8.com/S/PFE\">辉瑞</a>计划出售约6.3亿股<a href=\"https://laohu8.com/S/HLN\">Haleon</a>股票。</p><p><a href=\"https://laohu8.com/S/NIU\">小牛电动</a>盘前跌超3%，Q4营收同比下降21.8%。</p><p><a href=\"https://laohu8.com/S/LOGI\">罗技</a>股价盘前跌近6%，公司首席财务官辞职。</p><p>Shift4盘前跌超8%，公司CEO称潜在收购出价未充分反映价值。</p><h3 id=\"id_1154522510\">欧洲市场</h3><p>欧洲主要指数涨多跌少，德国DAX30涨0.36%，法国CAC40涨0.18%。</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/f2dbb9a82bf17cc786ea9c6de70cb5a9\" title=\"\" tg-width=\"1431\" tg-height=\"565\"/></p><h3 id=\"id_2405271039\">原油</h3><p>国际油价上涨，美油报81.09美元/桶，日内涨幅0.63%；布油现报85.80美元/桶，日内涨幅0.54%。</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/196fba7701318c85bdefd6a1b3424937\" title=\"\" tg-width=\"1415\" tg-height=\"90\"/></p><h3 id=\"id_89612189\">黄金</h3><p>现货黄金日内涨0.12%，报2,163.85美元/盎司。</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/50fe7834a761630db4d0282ac207cf48\" title=\"\" tg-width=\"560\" tg-height=\"240\"/></p><p></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/ed4ee39e6b0f45214393093d70ba81a8","relate_stocks":{"BK4588":"碎股","BK4551":"寇图资本持仓","LU0039217434.USD":"HSBC GIF CHINESE EQUITY \"AD\" INC","SMCI":"超微电脑","LU0106959298.USD":"UBS (LUX) EQUITY FUND - EMERGING MARKETS SUSTAINABLE LEADERS (USD) \"P\" (USD) ACC","LU0229945570.USD":"TEMPLETON BRIC \"A\" (USD) ACC","EH":"亿航智能","LU0320764599.SGD":"FTIF - Templeton China A Acc SGD","LU0052750758.USD":"富兰克林中国基金A Acc","LU1046422090.SGD":"Fidelity Pacific A-SGD","LU0289941410.SGD":"AB FCP I Dynamic Diversified AX SGD","BK4579":"人工智能","LU0965509101.SGD":"AB LOW VOLATILITY EQUITY PORTFOLIO \"A\" (SGDHDG) ACC","LU0256863811.USD":"ALLIANZ US EQUITY \"A\" INC","LU1316542783.SGD":"Janus Henderson Horizon Global Technology Leaders A2 SGD","NVDA":"英伟达","BK4550":"红杉资本持仓","BABA":"阿里巴巴","TSLA":"特斯拉","09988":"阿里巴巴-SW","GOOGL":"谷歌A","GOOG":"谷歌"},"source_url":"","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1190618566","content_text":"摘要：英伟达GTC大会重磅来袭，盘前股价涨近3%谷歌盘前涨超5%！报道：苹果正在谈判将谷歌的Gemini人工智能引擎植入iPhone高通推出第三代骁龙8s移动平台，支持终端侧生成式AI功能超微电脑今日起正式纳入标普指数特斯拉盘前涨超3%，宣布Model Y在欧洲多国提价首款国产“空中的士”淘宝开售！亿航智能盘前涨超13%辉瑞计划出售约6.3亿股Haleon股票3月18日，美股三大股指期货上涨，截止发稿，道指期货涨0.12%，纳指期货涨1.10%，标普500指数期货涨0.69%。盘前要闻英伟达GTC大会重磅来袭，盘前股价涨近3%3月18日-21日，英伟达AI大会GTC 2024将在美国圣何塞会议中心举行。今日（北京时间3月19日凌晨4点），英伟达CEO黄仁勋将进行主题为“面向开发者的1#AI峰会”演讲。据英伟达介绍，黄仁勋届时将发布加速计算、生成式AI以及机器人领域的最新突破性成果。市场普遍认为，此次大会焦点有4个：1.下一代Blackwell GPU架构，2.新款B100芯片，3.人形机器人，4.AI+医药。华尔街预计，本届GTC将帮助英伟达股票结束近期的震荡走势，并继续保持今年迄今超过80%的强劲增长势头。谷歌盘前涨超5%！报道：苹果正在谈判将谷歌的Gemini人工智能引擎植入iPhone据媒体援引知情人士消息，苹果与谷歌两家公司正在积极谈判，希望让苹果获得Gemini的授权，为今年iPhone软件的一些新功能提供支持。此外，苹果最近还与OpenAI进行讨论并考虑使用其模型。据报道，苹果希望获得相关许可，使用Gemini模型为iOS 18加入全新生成式AI功能。此前报道指出，分析师Mark Gurman透露，即将在今年6月发布的iOS 18，将会是苹果iOS史上最大更新，而其更新的关键就是围绕“AI”展开。首款国产“空中的士”淘宝开售！亿航智能盘前涨超13%今日全球首个获得适航认证的国产自研“空中的士”亿航EH216-S在淘宝上架，标价239万元。据悉，该“空中的士”为全智能无人驾驶航空器，可搭载两人，能够全智能低空飞行和垂直起降，完全不需要跑道。行业人士分析，作为新质生产力的代表，低空经济正走向落地普惠的阶段，“空中的士”的上架迈出了向低空自由飞行的坚实一步。受此消息影响，亿航智能盘前涨超13%。高通推出第三代骁龙8s移动平台，支持终端侧生成式AI功能北京时间3月18日下午，高通宣布推出全新的第三代骁龙8s移动平台，该平台将具备终端侧生成式AI功能以及始终感知的ISP。高通方面表示，骁龙8s平台支持绝大部分主流AI模型，包括百川智能的Baichuan-7B、谷歌旗下的Gemini Nano、Meta旗下的Llama 2和智谱ChatGLM等。受此消息影响，高通盘前涨超1%。辉瑞计划出售约6.3亿股Haleon股票英国消费保健巨头Haleon周一表示，辉瑞将出售其在该公司的约6.3亿股股份，将其持股减少到24%左右。辉瑞目前持有Haleon的32%股份，该公司去年5月宣布，计划在几个月内以“缓慢而有条理”的方式减持股权。Haleon在一份声明中表示，辉瑞出售其股份的价格预计将在3月19日左右公布，届时将完成簿记程序。福特汽车据称正开发一款售价2.5万美元的紧凑型电动车消息人士：福特汽车据称正在开发一款售价为2.5万美元的紧凑型电动车，预计将于2026年底首次亮相。福特汽车新的电动车平台将采用更便宜的锂铁磷酸(LFP)电池。福特汽车紧凑型车型是三款新的低成本电动车之一。盘前行情特斯拉(TSLA)$盘前涨超3%，宣布Model Y在欧洲多国提价2000欧元。当地时间上周六，特斯拉在X平台的官方账号宣布，将于3月22日在多个欧洲国家提高其Model Y电动汽车的价格，涨幅约为2000欧元(约2177美元)，或当地货币等值。此前一天，特斯拉宣布从4月1日起，将在美国销售的Model Y价格上调1000美元。这将是特斯拉Model Y一个月内第二次提价。3月1日，特斯拉已将Model Y后轮驱动版和远程版的价格分别提高了1000美元，至43990美元和48990美元。超微电脑盘前涨近3%，今日起正式纳入标普指数。部分中概股上涨，小鹏汽车涨超6%，蔚来涨超4%，哔哩哔哩、拼多多涨超2%。理想汽车盘前跌超5%，“MEGA”据报订单逊预期，管理层考虑下调销售目标。Haleon盘前跌超1%，辉瑞计划出售约6.3亿股Haleon股票。小牛电动盘前跌超3%，Q4营收同比下降21.8%。罗技股价盘前跌近6%，公司首席财务官辞职。Shift4盘前跌超8%，公司CEO称潜在收购出价未充分反映价值。欧洲市场欧洲主要指数涨多跌少，德国DAX30涨0.36%，法国CAC40涨0.18%。原油国际油价上涨，美油报81.09美元/桶，日内涨幅0.63%；布油现报85.80美元/桶，日内涨幅0.54%。黄金现货黄金日内涨0.12%，报2,163.85美元/盎司。","news_type":1},"isVote":1,"tweetType":1,"viewCount":108,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":283941172039760,"gmtCreate":1710338046315,"gmtModify":1710338047959,"author":{"id":"3537417120281286","authorId":"3537417120281286","name":"小白土兔","avatar":"https://static.tigerbbs.com/ed03e24159cdfb1a1cc9e0eb75d70106","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"都熄火了","listText":"都熄火了","text":"都熄火了","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/283941172039760","isVote":1,"tweetType":1,"viewCount":347,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":283881180807400,"gmtCreate":1710323269233,"gmtModify":1710323270888,"author":{"id":"3537417120281286","authorId":"3537417120281286","name":"小白土兔","avatar":"https://static.tigerbbs.com/ed03e24159cdfb1a1cc9e0eb75d70106","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"又开始炒作中概股，缺韭菜了吧","listText":"又开始炒作中概股，缺韭菜了吧","text":"又开始炒作中概股，缺韭菜了吧","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/283881180807400","isVote":1,"tweetType":1,"viewCount":159,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":283880662966360,"gmtCreate":1710323142671,"gmtModify":1710323245470,"author":{"id":"3537417120281286","authorId":"3537417120281286","name":"小白土兔","avatar":"https://static.tigerbbs.com/ed03e24159cdfb1a1cc9e0eb75d70106","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"和朋友聊到我在美股的中概股亏了很多钱，他说，人家中国企业不远万里是想着去割外国资本主义的韭菜，你倒好，非要跑去让人家割，被大a割的还不够吗？你亏了活该。 从此再也不碰中概股。中概股玩法和a股一样，没有武德，没有价值投资，中国人就别去被骗了吧","listText":"和朋友聊到我在美股的中概股亏了很多钱，他说，人家中国企业不远万里是想着去割外国资本主义的韭菜，你倒好，非要跑去让人家割，被大a割的还不够吗？你亏了活该。 从此再也不碰中概股。中概股玩法和a股一样，没有武德，没有价值投资，中国人就别去被骗了吧","text":"和朋友聊到我在美股的中概股亏了很多钱，他说，人家中国企业不远万里是想着去割外国资本主义的韭菜，你倒好，非要跑去让人家割，被大a割的还不够吗？你亏了活该。 从此再也不碰中概股。中概股玩法和a股一样，没有武德，没有价值投资，中国人就别去被骗了吧","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/283880662966360","isVote":1,"tweetType":1,"viewCount":172,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":283370305646904,"gmtCreate":1710210667536,"gmtModify":1710210669608,"author":{"id":"3537417120281286","authorId":"3537417120281286","name":"小白土兔","avatar":"https://static.tigerbbs.com/ed03e24159cdfb1a1cc9e0eb75d70106","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"中概股和大a一样，先腰斩再腰斩，然后疯涨20%哈哈哈哈。然后就说狂欢了。","listText":"中概股和大a一样，先腰斩再腰斩，然后疯涨20%哈哈哈哈。然后就说狂欢了。","text":"中概股和大a一样，先腰斩再腰斩，然后疯涨20%哈哈哈哈。然后就说狂欢了。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/283370305646904","isVote":1,"tweetType":1,"viewCount":568,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}